Document:

Exhibit 10.26

 

Form of Change of Control Agreement

 

[Date]

 

[Employee Name]

 

Dear [Employee Name]:

 

This letter serves to set forth the following benefit to be
provided to you in the event of an Acquisition (as defined below) of Omnicell,
Inc. (the “Company”).

 

Provided one of the following events occurs within twelve
(12) months following an Acquisition: (i) you are terminated without Cause (as
defined below); (ii) the principal place of the performance of your
responsibilities and duties is changed to a location outside of the San Mateo,
Santa Clara, or San Francisco counties; or (iii) there is a material reduction
in your responsibilities and duties without Cause; then (a) you shall receive
severance pay equivalent to twelve (12) months’ salary at your base rate of pay
in effect immediately prior to the occurrence of any of the triggering event
described above (and further provided that you execute Omnicell’s standard
waiver and release agreement); and (b) the unvested portion of each of the
stock options granted to you under the Company’s 1999 Equity Incentive Plan,
the 2003 Equity Incentive Plan and/or the 2004 Equity Incentive Plan shall
accelerate and immediately become fully-vested and exercisable.

 

An “Acquisition” as used herein shall mean any consolidation
or merger of the Company with or into any other corporation or other entity or
person in which the stockholders of the Company prior to such consolidation,
merger or reorganization shall own less than fifty percent (50%) of the voting
stock of the continuing or surviving entity of such consolidation, merger or
reorganization, any other corporate reorganization in which in excess of fifty
percent (50%) of the Company’s voting power is transferred , or any transaction
in which any person, together with its affiliates, accumulates fifty percent or
more of the Company’s voting power.

 

As used herein, “Cause” shall mean: (i) conviction of any
felony; (ii) participation in fraud, misappropriation, embezzlement or other
similar act of dishonesty or material misconduct against the Company or any
subsidiaries or affiliates thereof; or (iii) participation in any act
materially contrary to the Company’s best interest.

 

Acceleration may be limited in certain circumstances, in
particular, if any such acceleration the (“Benefit”) would (i) constitute a
“parachute payment” within the meaning of Section 280G of the Internal Revenue
Code and (ii) but for this amendment, be subject to the excise tax imposed by
Section 4999 of the Internal Revenue Code, then such Benefit will be reduced to
the extent necessary so that no portion of the Benefit would be subject to the
excise tax, as determined in good faith by the Company; provided, however, that
if, in the absence of any such reduction (or after such reduction), you believe
that the Benefit or any portion thereof (as reduced, if applicable) would be
subject to the excise tax, the Benefit shall be reduced (or further reduced) to
the extent determined by you in your discretion so that the excise tax would
not apply. If, not withstanding any such reduction (or in the absence of such
reduction), the Internal Revenue Service determines that you are liable for the
excise tax as a result of the Benefit, then you will be obligated to return to
the Company, within thirty (30) days of such determination by the IRS, a
portion of the Benefit sufficient such that none of the benefit retained by you
constitutes a “parachute payment” within the meaning of Code Section 280G that
is subject to the excise tax.

 

The Company is please to provide this benefit to you in
recognition of your continuing dedication to the success of the Company. Should
you have any questions regarding this matter, please contact the undersigned at
650-[xxx-xxxx].

 

 

Omnicell, Inc.Exhibit 10.17

 

*** Text omitted and filed
separately

with the Securities and
Exchange Commission

Confidential Treatment
Requested

Under 17 C.F.R. §§ 200.80 (b)
(4)

And 240.24b-2

 

DISTRIBUTION AGREEMENT

 

THIS DISTRIBUTION AGREEMENT (this “Agreement”) effective as of January
1, 2006 (the “Effective Date”), is entered into between BIOSITE INCORPORATED, a
corporation under the laws of the State of Delaware (“Biosite”), having a place
of business at 9975 Summers Ridge Road, San Diego, California 92121, and FISHER
SCIENTIFIC COMPANY L.L.C., a Delaware Limited Liability Company represented by
its FISHER HEALTHCARE division, (“FHC”), having a place of business at 9999
Veterans Memorial Drive, Houston, Texas 77038.

 

WITNESSETH

 

WHEREAS, Biosite and Curtin Matheson Scientific (predecessor in
interest to FHC) entered into a Distribution Agreement dated as of November 11,
1991 (as amended, the “1991 Distribution Agreement”), which terminated on
December 31, 1997.

 

WHEREAS, Biosite and FHC entered into a new Distribution Agreement
effective as of January 1, 1998 (as amended, the “1998 Distribution Agreement”),
which terminated on December 31, 2000.

 

WHEREAS, Biosite and FHC entered into a Distribution Agreement
effective as of January 1, 2001 (as amended, the “2001 Distribution Agreement”),
which terminated on December 31, 2003.

 

WHEREAS Biosite and FHC entered into a new Distribution Agreement
effective as of January 1, 2004, which was amended by Amendment No. 1 to
Distribution Agreement, Amendment No. 2 to Distribution Agreement, Amendment
No. 3 to Distribution Agreement, Amendment No. 4 to Distribution Agreement,
Amendment No. 5 to Distribution Agreement and that certain Letter from Thomas
Watlington to [***] dated March 31, 2004 (as amended, the “2004 Distribution
Agreement”). The 1991 Distribution Agreement, the 1998 Distribution Agreement,
the 2001 Distribution Agreement and the 2004 Distribution Agreement,
collectively, are referred to as the “Previous Distribution Agreements”.

 

WHEREAS, the parties desire to terminate the 2004 Agreement, and to
enter into this Agreement setting forth the terms of their business
relationship, effective as of the Effective Date.

 

NOW, THEREFORE, in consideration of the foregoing premises and the
respective covenants of the parties herein set forth, the parties hereby agree
as follows:

 

1.             Products.

 

(a)           For
purposes of this Agreement, the “Products” shall mean, collectively, [***], [***],
[***], [***], [***] and [***].

 

 

***Confidential
Treatment Requested

 

1

 

(b)           For
purposes of this Agreement, the “[***]” shall mean the Biosite products
described in Schedule N.

 

(c)           For
purposes of this Agreement, the “[***]” shall mean the Biosite products
described in Schedule B.

 

(d)           For
purposes of this Agreement, the “[***]” shall mean the Biosite products
described in Schedule C.

 

(e)           For
purposes of this Agreement, the “[***]” shall mean the Biosite products
described in Schedule D.

 

(f)            For
purposes of this Agreement, the “[***]” shall mean the Biosite products
described in Schedule E-1 and Schedule E-2.

 

(g)           For
purposes of this Agreement, the [***] shall mean the new [***] products which
FHC exercises its right under Section 1(k) to add to this Agreement.

 

(h)           For
purposes of this Agreement, [***] shall mean [***] that either
(i) comprise a new line of products launched after the Effective Date, or
(ii) are added after the Effective Date to a line of products (e.g., the [***]
line, [***] line, and [***] line) existing as of the Effective Date (other than
products that merely add, remove or substitute one or more new markers to an
existing product, or products that merely add one or more new features (e.g., a
multi-marker index) to an existing product). [***], without limitation, will
include (pending completion of clinical development and regulatory approval)
the [***], [***].

 

(i)            For
purposes of this Agreement, “Improved Products” shall mean all New Products
other than Uniquely New Products. Improved Products, without limitation, will
include (pending completion of clinical development and regulatory approval)
the [***] with [***] and [***] products currently under development by Biosite.

 

(j)            For
purposes of this Agreement, [***] shall mean [***], [***] and those [***] that
Biosite classifies (in its sole and absolute discretion, as evidenced by
express written notice to FHC) as [***]. Following [***] and [***], the [***]
by Biosite shall be classified by Biosite as an [***]. If a [***] merely [***]
one or more [***] to a previously launched [***], or a product that merely [***]
(e.g., a [***]) to a previously launched [***], then following [***], such [***]
also shall be an [***]; provided, however, for purposes of calculating the GSMR
for such [***] under Section 5(f), the first sale of such [***] by Biosite
to FHC hereunder shall be deemed to be either (i) the [***] of the [***]
of such [***] by Biosite to FHC hereunder, or (ii) the date of the [***]
of such previously launched [***] by Biosite to

 

 

***Confidential
Treatment Requested

 

2

 

FHC hereunder, in each case as determined by Biosite
in its sole discretion and set forth in a written notice to FHC.

 

(k)           If
Biosite desires to offer for sale in the Territory or Physician Office
Practices any new Biosite immunoassay diagnostic product (including any product
improvements, updates or product line extensions) (i) for which Biosite or
the applicable third party manufacturer has received all applicable
governmental approvals to sell and use in the Territory and Physician Office
Practices after the date of this Agreement, (ii) which Biosite is not
prohibited by law or contract from selling to FHC hereunder, and
(iii) which Biosite offers for sale, then Biosite shall offer to FHC in
writing the opportunity to add such new Biosite immunoassay diagnostic product
to this Agreement; provided, however, that (A) if at such time FHC has the
right to sell or distribute any product of a third party in the Territory which
is competitive with such new Biosite immunoassay diagnostic product (excluding
any product that meets one or more of the exceptions described in Section
3(b)(i)(i-vi), then Biosite shall have no obligation to offer to FHC the
opportunity to add such new Biosite immunoassay diagnostic product (or to any
improved or updated versions thereof) to this Agreement, and (B) if either
party has [***] under [***], then Biosite thereafter shall have no obligation
to offer to FHC the opportunity to add any new Biosite immunoassay diagnostic
product to this Agreement. Notwithstanding the preceding, in the event that
Biosite desires to offer for sale in the Territory or Physician Office
Practices any such new Biosite immunoassay diagnostic product as described
above, and at such time, FHC has the right to sell or distribute any product of
a third party in the Territory which is competitive with such new Biosite
immunoassay diagnostic product (excluding any product that meets one or more of
the exceptions described in Section 3(b)(i)(i-vi)), the parties shall negotiate
in good faith the terms under which Biosite would offer to FHC the opportunity
to add such new Biosite immunoassay diagnostic product (including any improved
or updated version or product line extension thereof) to this Agreement. If the
parties are unable to reach a mutually acceptable agreement for the
distribution of the applicable product after such good faith negotiations,
Biosite, at its sole option, shall have no obligation to offer such product to
FHC for distribution (or the product improvements, updates or product line
extensions thereof). Without limiting the generality of the foregoing, if as
part of the negotiations described in the preceding sentence FHC agrees to
discontinue the distribution of such competitive product as a condition
precedent to adding such new Biosite immunoassay diagnostic product to this
Agreement, Biosite shall be obligated to offer such new Biosite immunoassay
diagnostic product to Fisher under the terms of this Section 1(k). If FHC
gives Biosite express written notice of FHC’s acceptance of such offer for such
new Biosite immunoassay diagnostic product within [***] days after FHC receives
Biosite’s written offer to add such new Biosite immunoassay diagnostic product
to this Agreement, then such new Biosite immunoassay diagnostic product shall
be added to this Agreement (subject to Fisher’s discontinuation of the
distribution of such competitive product, if applicable, as a condition
precedent). If FHC fails to give Biosite express written notice of FHC’s
acceptance of such offer for such new Biosite immunoassay diagnostic product
within [***] days after FHC receives Biosite’s written offer to add such new
Biosite immunoassay diagnostic product to this Agreement, then FHC shall have
no rights in or to such new Biosite immunoassay diagnostic product (or to any
improved or updated versions thereof) under this Agreement or otherwise.

 

 

***Confidential
Treatment Requested

 

3

 

(l)            Biosite
shall provide all required Material Safety Data Sheets, if any, for any Product
containing hazardous chemicals or otherwise as required by federal, state or
local law.

 

2.             Grant
of Distributorship.

 

(a)           Upon
the terms and subject to the conditions set forth in this Agreement, Biosite
hereby appoints FHC, and FHC accepts such appointment, as the [***] distributor
of the Products in the Territory during the Term. For purposes of this
Agreement, “[***]” shall mean, with respect to any Product, that Biosite (under
the terms and conditions of Section 2(e)) and FHC (on the terms and conditions
in this Agreement) and [***] other third party (to be determined by Biosite, [***],
[***] or [***], or any of [***] or [***], and which [***], [***] or [***], or
any of [***] or [***], as a [***]), shall have the right to promote, market,
sell and distribute the Products in each segment of the Territory. During the
Term, Biosite shall not use [***], [***] or [***], or any of [***] or [***], as
a third party logistics provider for the Products in the Territory. Any agreement
between Biosite and such third party distributor allowed under this Section
2(a) shall contain language that prohibits during the Term the provision at any
point in the distribution chain other than for end-use, of Product to [***], [***]
or [***], or any of [***] or [***]. Biosite shall inform FHC of any such
appointment in writing not less than [***] days prior to initiating
distribution with any such third party. FHC may distribute the Products
hereunder only through FHC or its subdistributors existing as of the Effective
Date, which are listed in Schedule G. FHC shall not appoint subdistributors
hereunder, other than those listed in Schedule G without Biosite’s prior
express written consent, which shall not be unreasonably withheld. Notwithstanding
the foregoing, Biosite reserves the rights described in Section 2(e).

 

(b)           Notwithstanding
anything to the contrary set forth in this Agreement, upon the terms and
subject to the conditions set forth in this Agreement, Biosite hereby appoints
FHC, and FHC accepts such appointment, as the [***] distributor of the Products
in the [***] (as defined below) during this Agreement. FHC may distribute the
Products hereunder only through FHC or its subdistributors existing as of the
Effective Date, which are listed in Schedule G. FHC shall not appoint
subdistributors hereunder, other than those listed in Schedule G without
Biosite’s prior express written consent, which shall not be unreasonably
withheld.

 

(c)           The
“Territory” consists of [***] in the United States and its territories
(including without limitation, Puerto Rico): (1) the “[***]”, and (2) the “[***].”
The [***] shall mean:[***]. The [***] shall mean those [***] of [***] or more [***]
that have [***] from [***] any Product at any time [***], through [***], as
evidenced by

 

 

***Confidential
Treatment Requested

 

4

 

written notice provided by FHC to Biosite in
accordance with the 2004 Distribution Agreement. The Territory shall not
include any areas or any market segment not described in this Section 2(c)
without the prior written consent of Biosite, which consent may be withheld at
Biosite’s sole discretion. Other than as expressly set forth in Section 2(i)
regarding [***], FHC shall not be permitted to sell the Products in any areas
or to any market segment not described in this Section 2(c) without the prior
written consent of Biosite, which consent may be withheld at Biosite’s sole
discretion. FHC shall take reasonable steps to limit the likelihood that FHC’s customers
in the Territory and [***] purchase Products for resale in the [***] (as
defined below but not including the [***] of [***] or more [***]).

 

(d)           All
areas and market segments not included in the definition of the Territory and [***]
shall be hereinafter referred to as the “[***].” Biosite shall retain all
rights to promote, market, sell and distribute (either directly or through
others) the Products in the [***] and [***]. Except as otherwise set forth in
this Agreement, Biosite shall not be permitted to sell the Products in the
Territory and shall take reasonable steps to limit the likelihood that Biosite’s
customers in the [***] and [***] purchase Products for resale into the
Territory. Included in the [***], without limitation, are all market segments
in countries outside of the United States and its territories (including
without limitation, Puerto Rico) and the following customer groups in the
United States and its territories (including without limitation, Puerto Rico):
physician group practices of [***] or more physicians other than the [***];
probation and parole programs; public and private sector workplace testing;
industrial laboratories; non-hospital military on-site testing programs (i.e.,
ADCO, recruiting centers); high school, college, university and professional
sports programs; government agencies; public carriers; and veterinary clinics
and animal testing. For the sake of clarity, physician group practices of [***]
or more physicians other than the [***] shall be included in both the
definitions of [***] and [***].

 

(e)           Nothing
herein shall prohibit Biosite from:

 

(i)            promoting,
marketing, distributing and selling the [***] to [***] (or its affiliates)
without restriction;

 

(ii)           distributing
(but not selling) Products within the Territory only for purposes of pre-market
clinical testing or evaluation of Products or testing of Product improvements
or enhancements prior to market introduction or distributing (but not selling)
Products within the Territory for post-market research or educational purposes;

 

(iii)          promoting,
marketing, soliciting and receiving orders for the sale by FHC, its
subdistributors listed on Schedule G (with FHC’s consent), and its co-exclusive
distributor of Products within the Territory as allowed under the terms and
conditions of this Agreement;

 

(iv)          promoting,
marketing, selling and distributing any Product directly to a customer
(A) listed on Schedule 2(e)(iv) (B) which states in writing to FHC
(either directly

 

 

***Confidential
Treatment Requested

 

5

 

or through Biosite but that nevertheless is a writing
on customer letterhead) prior to Biosite’s first sale to such customer that
such customer will only buy such Product directly from Biosite (or any other
Biosite distributor properly appointed under the terms and conditions of this
Agreement), but only after Biosite identifies the customer to FHC’s Vice
President of Marketing (or his or her designee) and specifies the reason such
customer refuses to buy from FHC, or (C) who purchases not more than [***] of
Products during any [***] period, but only to the extent that the aggregate
amount of Products purchased by all such customers during such same twelve
month period is less than [***]; and

 

(v)           promoting,
marketing, selling and distributing, or permitting any third party to promote,
market, sell or distribute, any Product (A) in the [***], (B) in any territory
or market segment during the Extended Term (if applicable as described in
Section 6(a) of this Agreement), or (C) in the event that FHC exercises the opt
out right described in Section 3(b); provided, however, that the [***] shall
remain a [***] Product as defined in Section 2(a) above for the Term.

 

(f)            FHC
shall not negotiate or execute an agreement with a group purchasing
organization (integrated delivery network or similar entity) with respect to [***]
customers without the written consent of Biosite, which shall not be
unreasonable withheld. FHC shall pay any group purchasing organization’s
administrative fees applicable to FHC’s national contracts. Biosite shall pay
any group purchasing organization’s administrative fees applicable to Biosite’s
national contracts. Each of FHC and Biosite shall pay [***] of the
administrative fees imposed by [***], [***] regarding the purchase of the
Products through FHC, provided that neither party can amend the amount of
administrative fee imposed by [***] without the other party’s prior written
consent. The language contained in this Section 2(f) shall control over any
conflicting language contained in this Agreement.

 

(g)           (i)            If
FHC in good faith enters into a written agreement (excluding a purchase order
or Multi-product Agreement (as defined below)) with a Contract Customer (as
defined below) relating to the purchase and sale of Products, such written
agreement shall be substantially in the form of Biosite’s then-current form
written agreement for the applicable transaction (the “Form Agreement”),
provided that FHC may (1) remove the Biosite logo and insert the FHC logo, (2)
delete “Biosite” as the signatory, (3) insert terms concerning shipment and
payment as exist between FHC and the Contract Customer, (4) expressly provide
that Biosite and not FHC shall be responsible for all warranty services (in
accordance with Biosite’s standard warranty terms and conditions), and product
liability issues and third party intellectual property claims to the extent
caused by Biosite’s negligence or intentional misconduct, and (5) insert terms
and conditions limiting FHC’s liability to the applicable customer to the
extent permitted by applicable law (provided that such terms and conditions
shall in no event provide that Biosite shall have additional obligations or
liability to the applicable customer). Subject to the immediately preceding
sentence, FHC shall not revise the terms or conditions of a Form Agreement
without obtaining Biosite’s prior written approval.

 

(ii)           Subject
to Section 5(e) below, Biosite shall have the right to enter into written
agreements with Contract Customers of FHC for distribution of Products by FHC
to such Contract Customers, provided that Biosite shall not obligate FHC to:
(i) provide warranty

 

 

***Confidential
Treatment Requested

 

6

 

services or indemnity to Contract Customers regarding
the Products (and each such written agreement shall contain language
substantially similar to the language set forth in paragraphs A and B of
Schedule J attached to this Agreement); or (ii) deliver the Products other than
in accordance with FHC’s standard delivery terms and conditions unless (a) FHC
fails to reject, within three (3) business days after delivery of a written
request by Biosite to FHC’s Controller, Biosite’s request to include in the
Contract Customer agreement delivery terms that are inconsistent with FHC’s
standard delivery terms or (b) [***] agrees to be [***] for all additional [***]
to the extent resulting from the [***] being [***] terms. Subject to the
foregoing, the following shall apply: (1) Biosite shall use reasonable efforts
to include language substantially similar to the language set forth in
paragraphs A and B of Schedule J attached hereto in any agreement with a
Contract Customer as described in the preceding sentence; and (2) Biosite shall
provide written notice to FHC’s Legal Department in the event that Biosite
desires to enter into an agreement with a Contract Customer that does not
contain language substantially similar to the language set forth in paragraph B
of Schedule J and Biosite shall not enter into such an agreement with such
Contract Customer in the event that FHC’s Legal Department provides, within
three (3) business days after delivery of a written request by Biosite,
reasonable notice and reasons for rejecting such request by Biosite.

 

(iii)          The
parties shall cooperate in good faith to facilitate the execution by Contract
Customers of any such written agreement based on the applicable Form Agreement
and as provided in this Section 2(g). Provided that the purpose of the
agreement is not primarily for the distribution of Products by FHC, FHC may in
good faith enter into written agreements with FHC customers relating to the
distribution by FHC to such FHC customers of multiple products including
Products and multiple products of third party manufacturers (a “Multi-product
Agreement”).

 

(iv)          FHC
shall not obligate or give the right to any FHC customer to purchase any
Products beyond the Term, without the prior written consent of Biosite.

 

(v)           “Contract
Customer” shall mean a [***] that purchases a Product from [***] pursuant to a [***]
(excluding a [***]) between FHC and such customer whether [***] or [***];
provided, however, “Contract Customer” shall not include [***] with which [***]
has entered into its [***].

 

(vi)          Notwithstanding
anything to the contrary herein, if a Contract Customer’s agreement with FHC
has a term that extends beyond the Term for any reason, then such Contract
Customer’s agreement with FHC shall be assignable to Biosite following the
termination of this Agreement, provided that Biosite provides FHC with a letter
from the Contract Customer to FHC requesting the assignment of such Contract
Customer’s agreement to Biosite. If any Contract Customer does not so direct
FHC to assign its agreement to Biosite, FHC shall be responsible for servicing
such Contract Customer for the term of the Contract Customer’s agreement, if
that agreement should extend past the date of termination of this Agreement.
Any request for assignment of a FHC Contract Customer’s agreement shall be
subject to the provisions of Section 6(c) of this Agreement with respect to
mutual agreement of the Message. In order to allow FHC to service non-assigning
Contract Customers following the

 

 

***Confidential
Treatment Requested

 

7

 

termination of this Agreement, Biosite shall, if FHC
so elects, sell Products to FHC upon the terms and conditions set forth herein
following the termination of this Agreement for distribution to the
non-assigning Contract Customers, and the terms and conditions of this
Agreement shall survive to the extent applicable to the sale by Biosite to FHC,
and the subsequent distribution by FHC to the non-assigning Contract Customers
(and not to any other customer), of such Products. For the avoidance of doubt,
it is understood that during any such period, the relationship between FHC and
Biosite shall be non-exclusive.

 

(h)           Notwithstanding
anything to the contrary, upon [***] advance written notice to FHC (the “Event
Notice”), Biosite may, in its sole discretion, (i) discontinue the manufacture,
sale or supply of [***] into the general commercial market (but not to FHC
only), and (ii) sell or transfer its [***] line of products (or such portion of
Biosite’s business that pertains to the [***]). [***] days after receipt of an
Event Notice, (i) FHC shall no longer have the right to distribute, and shall
cease distributing, the [***] other than such [***] that are already in FHC’s
inventory, and (ii) this Agreement shall terminate with respect to [***] only,
subject to Section 6(c) and other than for purposes of Sections 5(g) and 5(h).

 

(i)            Notwithstanding
anything to the contrary set forth in the Agreement, upon the terms and subject
to the conditions set forth in this Agreement and clauses (i) through (vi) of
this Section 2(i), Biosite appoints FHC, and FHC accepts such appointment, as a
non-exclusive distributor of the Products in the [***].

 

(i)            At
Biosite’s request, Fisher shall submit to Biosite such reports as are
customarily provided by FHC to suppliers similarly situated with Biosite. All
such sales reports are, and shall remain the property of FHC, and shall be
subject to Section 9 of this Agreement, but may be used by Biosite solely for
the purposes of performance of its obligations and the exercise of its rights
under the Agreement.

 

(ii)           FHC
may distribute the Products hereunder only through FHC or its subdistributors
existing as of the Effective Date, which are listed in Schedule G of this
Agreement. FHC shall not appoint subdistributors hereunder, other than those
listed in Schedule G without Biosite’s prior express written consent, which
shall not be unreasonably withheld.

 

(iii)          With
respect to sales to [***], each party shall perform its obligations as set
forth in Schedule M.

 

(j)            “[***]”
means [***] the premises of the foregoing [***], but specifically excluding (i)
the [***], (ii) [***] (including [***]), including, but not limited to the [***],
(iii) [***] that are not specified above, (and (iv) the [***]. “[***]” means
those [***] and [***] located within the premises of the foregoing

 

 

***Confidential
Treatment Requested

 

8

 

[***], who prior to [***], received a [***] from or
through an [***] to the customer.

 

3.             Conduct
of FHC.

 

(a)           During
the Term, FHC shall use its good faith commercial efforts and facilities
(i) to promote, market, distribute and sell the Products within the
Territory and [***], and (ii) to take no action which would interfere with
Biosite’s efforts to develop and maintain the reputation of and goodwill with
respect to the Products, provided that the parties acknowledge that FHC’s
actions allowed by the second sentence of Section 3(b)(i) shall not constitute
a breach of the foregoing obligation. During such period after the Term that
FHC continues to have the right hereunder to sell Products to any customers,
FHC shall use its good faith commercial efforts and facilities (i) to
promote, market, distribute and sell the Products to such customers, and
(ii) to take no action which would interfere with Biosite’s efforts to
develop and maintain the reputation of and goodwill with respect to the
Products, provided that the parties acknowledge that FHC’s promoting,
marketing, distributing and selling products that are competitive with the
Products during the Period after the Term shall not constitute interference
with Biosite’s efforts to develop and maintain the reputation and goodwill with
respect to the Products. During the Term, FHC shall provide not less than an
aggregate of [***] full pages of advertising for available Products in all of
FHC’s General Catalogs. With respect to each [***] and [***], FHC shall permit
Biosite access to its sales representatives for at least one full day per
Product for the purpose of providing training of FHC’s sales representatives in
the demonstration and use of the Products on such dates (which shall be not
later than [***] months following the launch of such Product in the Territory
and [***]) and in such locations as mutually acceptable to the parties. FHC
shall provide Biosite with samples of any such Product advertising and sales
literature prior to printing and distribution of same, and Biosite shall have
the right to approve the Product advertisement(s), which approval shall not be
unreasonably withheld or delayed. FHC shall use its good faith commercial
efforts to inform customers and potential customers of the availability and
desirability of the Products; to handle promptly all inquiries, quotations,
correspondence and orders; and to assist customers in the proper use of the
Products and the referral of customers to Biosite for the solution of technical
application problems.

 

(b)           Non-Compete.

 

(i)            Except
as otherwise set forth in this Section 3(b), and except with respect to
the [***], provided that Biosite supplies sufficient Products to FHC to satisfy
FHC’s purchase of the Products from Biosite within FHC’s reasonable forecasted
amounts pursuant to Section 3(c), FHC shall not promote, market,
advertise, sell, or distribute any products in the Territory that are directly
competitive with the Products, other than the [***], to which this section
shall be inapplicable. Notwithstanding the foregoing, FHC shall have the right
to promote, market, advertise, distribute and sell (i) products of a third
party, competitive with the Products, which third party products FHC sells or
distributes as of the Effective Date, as listed on Schedule H;
(ii) any products of such third party which are subsequently added by such
third party to its line of products listed on Schedule H, which are
competitive with the Products, except those products in the same or equivalent
testing format of the Products that read visually or read on a point of care
instrument; (iii) any instruments that

 

 

***Confidential
Treatment Requested

 

9

 

may include competitive
assays to the Products which are instruments that are based on an automated
random access instrument platform (with the exception of those instruments
manufactured by or on behalf of [***], [***], [***], [***], [***] or [***] or
their successors or assigns and which have a [***]) with a broad based menu of
analytes such as chemistries, fertility, thyroid function, oncology, infectious
disease, TDM, DOA, allergy, etc.; provided that all of the products referred to
in Sections 3(b)(i)(iii) have a [***]; (iv) products of a third party which FHC
sells or distributes as of the date that Biosite offers a new product to FHC
under Section 1(k) of this Agreement, which products are competitive with the
new product; provided, however, in each case that FHC immediately shall notify
Biosite in writing of such products and if the parties mutually agree to terms
under which FHC may distribute the new Biosite product, then such competitive product
shall be added to Schedule H; (v) any products of such third party which are
subsequently added by such third party to its line of products described in
clause (iv) above, which are competitive with the Products, except those
products in the same or equivalent testing format of the Products that read
visually or read on a point of care instrument; provided, however, in each case
that FHC immediately shall notify Biosite in writing of such products and if
FHC elects to carry the new product then such competitive product shall be
added to Schedule H; (vi) products (including instruments) of [***] or [***]
(and any improvements, updates or extensions thereof)) marketed as of the
Effective Date by [***] or [***] regardless of the list price of such instruments;
and (vii) subject to Section 6(a)(i) products that are manufactured by an
affiliate of FHC that are competitive with the Products. For the avoidance of
doubt, notwithstanding the foregoing, except as may be permitted under
Subsections (A) and (B) below and as may be permitted under Section 6(a)(ii),
FHC shall not promote, market, advertise, sell, or distribute any products in
the Territory for [***] other than (A) products (including instruments) of
[***] or [***] (and any improvements, updates or extensions thereof)) marketed
as of the Effective Date by [***] or [***] regardless of the list price of such
instruments, and (B) Products. Additionally, nothing contained in this
Agreement shall restrict the activities of FHC outside the Territory with respect
to competing products. FHC may opt out of the requirements of this Section 3(b)
at any time during the Extended Term by providing express written notice
thereof to Biosite.

 

(A)                                                            In
addition to the activities specifically allowed in Subsections (i) – (vii) of
this Section 3(b)(i), with respect to any new Biosite product that is [***]
that Biosite intends to sell as a [***] product ([***]), if Biosite is
prohibited by contract from offering the [***] to FHC, then FHC shall have the
right to promote, market, advertise, distribute and sell any product that [***]
the same [***] but does not [***] any other of the [***] that [***] any
Products.

 

(B)                                                              In
addition to the activities specifically allowed in Subsections (i) – (vii) of
this Section 3(b)(i), with respect to a Biosite product that is [***] of more 

 

 

***Confidential
Treatment Requested

 

10

 

than [***] (“[***]”), if Biosite is
prohibited by contract from offering the [***] to FHC for distribution under
this Agreement, then FHC shall have the right to promote, market, advertise,
distribute and sell any product that measures any [***] that [***] the [***]
other than a [***] that [***] any Products.

 

(ii)           No
later than the earlier of [***] days after Biosite’s quarterly public
disclosure of its financial results (“Financial Results”) or [***] days after
the end of each calendar quarter (provided that Biosite has received from FHC
on a timely basis any information reasonably necessary for Biosite to perform
such calculation), Biosite shall calculate and provide FHC with a reasonably
detailed written report calculating with respect to the applicable [***] period
evidenced (or to be evidenced) in the Financial Results: (A) the sales of [***]
and its affiliates [***] unaffiliated [***] in the [***] (“[***]”) and
(B) the sale of [***] and its affiliates [***] unaffiliated [***] in the [***]
plus [***] sales in the [***] less the applicable [***], or other similar
adjustments between Biosite and FHC, for such Product sales (the sum of which
shall be referred to as “[***]”), in each case net of all [***] and other [***]
by [***] or its affiliates to any such [***]. If the [***] for such period
exceeds [***] of the [***] for such period, then upon written notice by FHC (at
the option of FHC in its sole discretion) delivered to Biosite within [***]
days after the receipt from Biosite of Biosite’s written report, the
provisions of Section 3(b)(i) immediately shall terminate and FHC shall
have the right to sell any products that compete with the Products at its sole
discretion. If FHC makes such election, then without any action by either
party, (1) FHC’s distributorship shall become [***] and Biosite shall have
the right to promote, market, advertise, distribute and sell Products direct to
any customer or to enter into one or more distribution agreements with any
third party (without restriction or obligation to FHC), and (2) either
party thereafter shall have the right to terminate this Agreement on [***] days
prior written notice to the other party. The provisions of Section 3(j)
shall be applicable to any data necessary to verify the calculations as
provided hereunder.

 

(iii)          FHC
represents to Biosite that, as of October 19, 2005, , there are no products
manufactured by affiliates of FHC that are competitive with the Products,
except as set forth on Schedule 3(b)(iii). FHC shall immediately notify Biosite
in writing if, after the Effective Date, an affiliate of FHC or FHC elects to
distribute or sell any product described in clause (vii) of
Section 3(b)(i). Concurrently with the execution of this Agreement, FHC
shall provide Biosite a list of affiliates that manufacture, distribute or sell
products in the United States as of the date of October 19, 2005. Such list
shall be deemed FHC Confidential Information and subject to the provisions of
Section 9.

 

(c)           FHC
shall provide Biosite, on a monthly basis, with a written forecast of FHC’s
estimated purchase requirements for each month in the ensuing three-month
period for the Products (other
than [***]), and in the ensuing six month period for [***]. Forecasted
quantities for Products for the first and second month of each forecast period
shall be

 

 

***Confidential
Treatment Requested

 

11

 

binding, subject however to a variance of plus or
minus [***] for the second month of each forecast and provided that in the
first [***] months following the date of first Product shipment for any new
Product, the second month forecast shall be subject to a variance of plus or
minus [***]. Biosite shall use its good faith commercial efforts to sell such
quantities to FHC. FHC shall include in each monthly forecast a good faith
estimated allocation of FHC’s estimated purchase requirements for each month
set forth in such report between the Territory and [***]; provided, however,
that such estimated allocation is solely for informational purposes, shall not
be binding on the parties and shall be used by Biosite solely for planning and
administrative purposes.

 

(d)           FHC
may return, for full credit or replacement, any Product for which FHC is
required to give a customer a credit or replacement Product due to a claimed
defect or deficiency in the Product, provided that FHC first obtains from
Biosite a returned goods authorization which shall not be unreasonably withheld
or delayed by Biosite.

 

(e)           Biosite
shall review and advise FHC on compliance with all FDA requirements regarding
the Products contained in FHC’s advertising and sales literature.

 

(f)            FHC
hereby represents and warrants that neither FHC nor its agents or employees
will make any representations or claims with respect to the Products which are
not authorized in writing by Biosite. Subject to the provisions of
Section 6(c) hereof, FHC agrees to and shall indemnify Biosite against,
and hold Biosite harmless from, all claims, actions, costs, expenses and
damages (including without limitation reasonable attorneys’ fees and expenses)
arising out of: (i) representations or claims by FHC with respect to the
Products which are not authorized by Biosite; (ii) willful act or omission
by or on behalf of FHC in connection with the sale, marketing, promotion or
distribution of the Products; (iii) failure by FHC to comply in any
material respect with governmental regulatory requirements relating to the
Products which are applicable to distributors of products; or
(iv) material breach of this Agreement by FHC. Such indemnity shall be
provided in accordance with the procedures set forth in Section 4(l) of
this Agreement.

 

(g)           Each
shipment from Biosite shall contain numbers identifying the manufacturing lot
or lots for control purposes. FHC shall keep accurate records that will enable
FHC to determine the Product lots received by specific customers of the Product.
FHC shall make such information available to Biosite in the event of a Product
recall or Product corrective action requested by Biosite or required by any
governmental agency as soon as reasonably practicable but in no event later
than ten (10) days after such request by Biosite. FHC shall provide
Biosite with information regarding the prior month’s sales including the [***],
and shall provide Biosite with such information in no event later than the last
day of the month, during the Term and during any time thereafter that FHC sells
any Product as permitted hereunder. Additionally, within ten (10) days after
each of the Effective Date, not less than [***], and not more than [***], days
prior to the commencement of the [***] and the [***] (if any), and within [***]
days after the termination of this Agreement, FHC shall provide to Biosite [***].

 

 

***Confidential
Treatment Requested

 

12

 

(h)           FHC
shall comply with Biosite’s reasonable instructions regarding the storage and
handling of the Products, and except as otherwise provided in this Agreement,
FHC shall be solely responsible for the cost thereof.

 

(i)            At
Biosite’s request, FHC shall submit to Biosite such other reports as are
customarily provided by FHC to suppliers similarly situated with Biosite.

 

(j)            Both
parties shall keep accurate records [***] of [***] for the [***]. Upon [***]
and upon [***] during [***], each party shall [***] an [***] reasonably
acceptable [***] being [***] or other [***] of the [***] being [***] to [***]
such records in order to [***] any [***] or [***] reasonably required by the
provisions of this Agreement, provided that [***] such [***] shall be permitted
and the parties shall not be required to [***] such [***] for [***]. All
information received as a [***] such [***] shall be subject to Section 9 of
this Agreement.

 

(k)           FHC
shall promptly advise Biosite of any changes in FHC’s organization or personnel
which may materially, adversely affect FHC’s ability to perform under this
Agreement, as well as any material changes affecting ownership or control of
FHC.

 

(l)            At
all times during the Term and during any time thereafter that FHC sells any
Product as permitted hereunder, FHC shall maintain inventory of each Product
sufficient to satisfy not less than FHC’s requirements for its reasonably
forecasted sales of such Product for the immediately following [***].

 

(m)          FHC
shall treat each [***] Product as [***], “[***]” or [***] status for [***]
purposes for not less than the first [***] full calendar quarters during which
such Product is an [***] Product hereunder. The [***] Products shall also be
included in the portfolio of products handled by FHC’s product specialists.

 

(n)           To
the extent otherwise permitted under this Agreement, if Biosite in good faith
enters into a bona fide written agreement (a “Biosite/GPO Agreement”) with a
group purchasing organization, integrated delivery network or similar entity
(collectively, a “GPO”) pursuant to which (i) the facilities in the Territory
having the right to purchase products under such GPO shall be obligated to
purchase one or more Products at a purchase price (the “GPO Price”) specified
in, or calculated under, such Biosite/GPO Agreement, the effective price to
FHC, for Products sold to FHC for resale under such Agreement hereunder solely
for resale to such facilities, shall be not greater than [***]. If Fisher
objects to such pricing then the parties shall exercise good faith efforts to
negotiate mutually agreeable pricing for a period of not less than fifteen (15)
days. If the parties are unable to reach agreement on other pricing
arrangements, then during the term of the GPO Agreement, Biosite shall have the
right to promote, market, sell and distribute such Products to such GPO under
the GPO Agreement, if Fisher refuses to sell the Products to the GPO member(s)
at the GPO Price.

 

 

***Confidential
Treatment Requested

 

13

 

(o)           To
the extent that Section 952 of the Omnibus Reconciliation Act of 1980 (the “Act”)
and the regulations promulgated thereunder are applicable to the distribution
or delivery of Products to a customer, during the term of any written agreement
with such customer and until the expiration of four (4) years after the last
sale of a Product by FHC pursuant to such customer agreement, FHC will make
available, to the same extent that Biosite is required to do so under the
customer agreement, upon written request of the Secretary of Health and Human
Services or the Comptroller General of the United States or any of their duly
authorized representatives, copies of any books, documents, records and other
data of FHC that are necessary to verify the nature and extent of the costs
incurred by the applicable customer in purchasing the Products.

 

4.             Conduct
of Biosite.

 

(a)           Biosite
shall ship promptly FHC’s orders for Products, but in any event not later than [***]
days from receipt of each order for a Product, (other than [***]). Biosite
shall use its reasonable efforts to ship FHC’s orders for [***] not later than [***]
from receipt of each order for [***]. Subject to the provisions of Section 11
hereof, Biosite shall ship FHC orders for Products [***] (at which point title
and risk of loss shall pass from Biosite to FHC), [***] or to such [***] as [***]
may [***]. Biosite shall cooperate with FHC in arranging drop shipments of
Products to customers on a case by case basis to include Products designated by
Biosite as drop ship Products. [***]. [***].

 

(b)           Biosite
shall notify FHC immediately in writing should Biosite become aware of any
defect or condition which may render any Product in violation of any statute or
regulation, or which in any way materially alters the specifications or quality
of such Product.

 

(c)           Biosite
shall provide to FHC’s sales personnel, at FHC’s premises or such other
location as the parties may agree, at mutually convenient times, such training
in the demonstration and use of the Products as may be reasonably requested by
FHC. During such training, Biosite shall also address, in a reasonable manner,
market information, strategies, and tactics to assist FHC’s performance of its
obligations under this Agreement. All training material, instructors,
demonstration/training products and other training costs and expenses therefor shall
be borne by Biosite; provided, however, that FHC shall, at its expense, provide
transportation and lodging for FHC personnel attending such training.

 

(d)           Biosite
shall provide technical support to FHC’s sales personnel and customers and
promptly provide to FHC such additional technical information developed or
acquired by Biosite from time to time as may reasonably be expected to be of
assistance to FHC in fulfilling its obligations hereunder. Biosite will
provide, at its own expense, a toll free long distance telephone service for
technical support for FHC customers and sales representatives.

 

(e)           Biosite
shall provide at its expense reasonable quantities of such instruction manuals
and point of sale literature as may from time to time be requested by FHC

 

 

***Confidential
Treatment Requested

 

14

 

for use in connection with the distribution of the
Products. Subject to FHC’s and Biosite’s prior written approval, the FHC name
will be incorporated in Biosite’s advertising and literature intended for
distribution in the Territory by FHC sales representatives, at FHC’s expense. If
requested to do so by FHC, Biosite shall furnish FHC with suitable copy and
photographs and other materials which the parties reasonably agree for use by
FHC in cataloging the Products.

 

(f)            During
the Term, Biosite shall provide FHC, upon request, with up to the number of
Samples (as defined below) of each Product set forth on Schedule F, at the [***]
set forth in Schedule F, to be used by FHC solely in connection with the
promotion and marketing of such Product. A “Sample” shall mean, with respect to
a Product, a sample unit of such Product [***] solely for the purpose of
marketing and promoting such Product, and not for the purpose of commercial
resale. Such Samples may not be sold by FHC and shall be marked by Biosite with
the following legend: “FOR EVALUATION PURPOSES ONLY - NOT FOR RESALE.”

 

(g)           Any
Products owned by FHC and rendered unsalable, in FHC’s reasonable commercial
judgment, due to a change in any Product specification, discontinuation or
elimination by Biosite of any Product from its product offering, release by
Biosite of any materially improved or updated version of any Product, or any
other material change in the Product outside of FHC’s control shall be
repurchased from FHC by Biosite within thirty (30) days following FHC’s request
therefor at the price paid for such Product(s) by FHC. Biosite shall
additionally pay for return freight and related transportation and insurance
charges for all such Products. Biosite’s release of a Product which has a
longer shelf life shall not be deemed a material improvement under this Section
4(g).

 

(h)           Biosite
shall promptly provide FHC with leads concerning prospective purchasers of the
Products within the Territory in a format to be mutually agreed upon between
the parties.

 

(i)            Biosite
shall provide full and accurate written instructions on the Bill of Lading
regarding the storage and handling of the Products.

 

(j)            Biosite
shall ship the Products so that at least [***] of the shelf life of the
Products will be remaining at the time of receipt at FHC’s facility, or at FHC’s
customer’s facility, if drop shipped. Biosite shall take back for full credit
plus shipping charges any dated Products shipped contrary to this provision,
unless shipment of such short-dated Products was pre-approved in writing by
FHC.

 

(k)           Biosite
shall indemnify and hold FHC harmless from and against all losses, liabilities,
damages and expenses (including reasonable attorneys’ fees and costs) resulting
from all claims, demands, actions and other proceedings to the extent resulting
from (i) representations or claims by or on behalf of Biosite with respect to
the Products that are untrue or materially misleading when made; (ii) willful
act or omission by or on behalf of Biosite in the sale, marketing, promotion or
distribution of the Products hereunder; (iii) failure by Biosite to comply in
any material respect with governmental regulatory requirements relating to the
Products; (iv) infringement of any of the Products on any intellectual property
rights of third parties; or (v) material breach of this Agreement by Biosite.

 

 

***Confidential
Treatment Requested

 

15

 

(l)            A
party (the “Indemnitee”) that intends to claim indemnification under Section
3(f) or Section 4(k) shall promptly notify the other party (the “Indemnitor”)
of any claim, demand, action or other proceeding for which the Indemnitee
intends to claim such indemnification. The Indemnitor shall have the right to
participate in, and to the extent the Indemnitor so desires jointly with any
other indemnitor similarly noticed, to assume the defense thereof with counsel
selected by the Indemnitor; provided, however, that the Indemnitee shall have
the right to retain its own counsel, with the fees and expenses to be paid by
the Indemnitor, if representation of the Indemnitee by the counsel retained by
the Indemnitor would be inappropriate due to actual or potential differing
interests between the Indemnitee and any other party represented by such
counsel in such proceedings. The indemnity obligations under Section 3(f) and
Section 4(k) shall not apply to amounts paid in settlement of any claim,
demand, action or other proceeding if such settlement is effected without the
prior express written consent of the Indemnitor, which consent shall not be
unreasonably withheld or delayed. The Indemnitor may not settle or otherwise
consent to an adverse judgment in any such claim, demand, action or other
proceeding, that diminishes the rights or interests of the Indemnitee without
the prior express written consent of the Indemnitee, which consent shall not be
unreasonably withheld or delayed. The Indemnitee, its employees and agents,
shall reasonably cooperate with the Indemnitor and its legal representatives in
the investigation of any claim, demand, action or other proceeding covered by
Section 3(f) or Section 4(k), as applicable.

 

5.             Price
and Payment Terms.

 

(a)           Biosite
shall charge FHC a Transfer Price for each [***] equal to the [***] Price (as
defined below) for such [***] in effect on the date of FHC’s purchase order
therefor.

 

(b)           Subject
to Sections 5(k) and 5(l), Biosite shall charge FHC a Transfer Price per unit
for each Product (other than Samples), equal to the List Price, as defined
below in Section 5(f) for such Product, less the following discount:

 

(i)            [***]
for [***], except for the [***] (Catalog No. [***]) and the [***] (Catalog No. [***])
which shall be discounted [***].

 

(ii)           [***]
for [***] sales.

 

(iii)          [***]
for [***] sales, except for [***] (Catalog No. [***]), [***] (Catalog No. [***])
and [***] (Catalog No. [***]) which shall be discounted [***].

 

(iv)          [***]
for [***] set forth on Schedule E-1.

 

(v)           [***]
for [***] set forth on Schedule E-2 and [***] sales.

 

 

***Confidential
Treatment Requested

 

16

 

(vi)          Notwithstanding
any provision of Section 5(b) to the contrary, the Transfer Price for the [***]
Products shall equal the applicable List Price, less [***].

 

(vii)         Notwithstanding
any provision of Section 5(b) to the contrary, the Transfer Price for each
Product listed on Schedule K shall be as set forth on Schedule K.

 

The parties shall meet not less than yearly and
attempt to reach mutually acceptable agreement on any necessary or desirable
revisions to the applicable discounts from List Price per Product category
(including those necessary or desirable to reflect an attempt to minimize
additional payments from FHC to Biosite and/or rebates from Biosite to FHC).

 

(c)           [***]
and the [***] set forth on Schedules B, C, D, E-1, E-2 and N [***]; provided,
however, that [***] shall give at least [***]. [***] shall honor [***] at the [***]
in effect immediately [***] the [***] of [***].

 

(d)           FHC
shall pay for [***] and Products purchased pursuant to this Agreement [***]
after the date of Biosite’s invoice.

 

(e)           FHC
shall be entitled to resell the Products on such terms as it may, in its sole
discretion, determine, including, without limitation, price, returns, credit,
discounts, and promotions.

 

(f)            For
purposes of this Section 5, the following definitions shall apply:

 

“Actual Selling Margin” shall mean Actual Selling Price - Transfer
Price.

 

“Actual Selling Margin Rate” or “ASMR” shall mean:

 

[Actual Selling Price - Transfer Price]

Actual Selling Price

 

“Actual Selling Price” shall mean, with respect to any Product (other
than [***]), the invoiced sales price, net of any discounts actually taken,
which FHC or its affiliate charges to an unaffiliated customer for purchase of
such Product.

 

“Guaranteed Selling Margin Rate” or “GSMR” shall mean, with respect to
any Product (other than Samples), the margin rate that is set forth below for
such Product.

 

“List Price” shall mean Biosite’s then-current list price for a
Product, which list price may be adjusted only as provided in Section 5(c)
above. The List Price for each Product as of the Effective Date of this
Agreement (but subject to adjustment thereafter in accordance with Section
5(c)) is as set forth in the applicable exhibit attached hereto.

 

“[***] Price” shall mean, with respect to any [***], the price therefor
set forth on Schedule F, as amended from time to time pursuant to Section 5(c).

 

 

***Confidential
Treatment Requested

 

17

 

“Transfer Price” shall mean, with respect to any Product (other than [***]),
the price calculated pursuant to Section 5(b) above which FHC is obligated to
pay to Biosite for purchase of such Product.

 

Subject to the provisions of Section 5(i) below, FHC shall receive the “Guaranteed
Selling Margin Rate” on Products as set forth below.

 

(i)            The
GSMR for sales of each [***] to hospitals with [***] (excluding sales for
evaluation or sample purposes) shall be as follows:

 

	
  Through the
  end of the [***] after the first sale of such Product by Biosite to FHC
  hereunder

  	
   

  	
  [***]

  
	
  From the
  [***] after the first sale of such Product by Biosite to FHC hereunder

  	
   

  	
  [***]

  
	
  From the
  [***] after the first sale of such Product by Biosite to FHC hereunder

  	
   

  	
  [***]

  
	
  After the
  end of the [***] after the first sale of such Product by Biosite to FHC
  hereunder

  	
   

  	
  [***]

  

 

(ii)           The
GSMR for sales of each [***] to hospitals with [***] (excluding sales for
evaluation or sample purposes) shall be as follows:

 

	
  Through the
  end of the [***] after the first sale of such Product by Biosite to FHC
  hereunder

  	
   

  	
  [***]

  
	
  From the
  [***] after the first sale of such Product by Biosite to FHC hereunder

  	
   

  	
  [***]

  
	
  From the
  [***] after the first sale of such Product by Biosite to FHC hereunder

  	
   

  	
  [***]

  
	
  After the
  end of the [***] after the first sale of such Product by Biosite to FHC
  hereunder

  	
   

  	
  [***]

  

 

(iii)          For
the purposes of this Agreement, with respect to the [***], the “first sale of
such Product by Biosite to FHC hereunder” as provided in Sections 5(f)(i) and
(ii) immediately above shall be deemed to have occurred on the Effective Date. The
GSMR for sales of all Products (other than [***]) to all hospitals shall be [***].

 

For the purpose of determining the applicable Guaranteed Selling Margin
Rate a “hospital” shall mean a building or real estate improvement and not a
group of affiliated entities.

 

 

***Confidential
Treatment Requested

 

18

 

(g)           In
accordance with the payment terms set forth in Section 5(d) above, Biosite
shall receive payment of the Transfer Price for Products shipped to FHC. Subject
to the provisions of Section 5(i) below, should the Actual Selling Margin Rate
be less than the GSMR for a Product unit, FHC is entitled to a rebate from
Biosite for such Product unit. The rebate is calculated as follows:

 

[***]

 

(h)           Subject
to the provisions of Section 5(i) below, should the ASMR exceed the GSMR for a
Product unit, FHC will make an additional payment to Biosite for such Product
unit. The additional payment is calculated as follows:

 

[***]

 

(i)            Within
[***] after the end of each calendar month, FHC shall prepare and provide
Biosite with a reasonably detailed written sales report which shall (i) set forth
on a Product-by-Product basis the sales of Products by FHC and its affiliates
to unaffiliated customers, and (ii) calculate on a Product-by-Product basis the
Actual Selling Price, the ASMR and the GSMR therefor, and the net amount (if
any) of the additional payments from FHC to Biosite and/or the rebates from
Biosite to FHC owing under Section 5(g) for such calendar month. Such sales
reports are, and shall remain the property of FHC, and shall be subject to
Section 9 of this Agreement, but may be used by Biosite solely for the purposes
of performance of its obligations and the exercise of its rights under this
Agreement. Such report shall be based on sales by FHC and its affiliates, as
reflected on FHC’s Key Supplier Report, on each Product during each calendar
month. FHC shall pay to Biosite any such additional payment, and Biosite shall
pay to FHC any such rebate, owing under Section 5(g) for each calendar month on
or before the later of the fifteenth (15th) day of the following calendar month
or ten (10) days after Biosite’s receipt of the applicable sales report for
such calendar month. Biosite and its agents shall have the right, through an
independent auditor chosen by Biosite and reasonably acceptable to FHC, on
reasonable notice and not more than twice in each calendar year, to inspect and
audit the relevant books and records of FHC and any of its relevant affiliates
to verify the accuracy of such sales reports. Biosite shall pay the fees and
expenses of such audit.

 

(j)            Except
as set forth below in this Section 5(j) or as the parties otherwise mutually
agree, if the Actual Selling Price of any Product unit is less than the List
Price of such Product less [***], then for purposes of calculating ASMR and
GSMR, and the amount of any rebate or additional payments under Section 5(g),
the Actual Selling Price of such Product unit shall be deemed to be List Price
of such Product less [***]. The foregoing limitation on the calculation of
Actual Sales Price shall not apply to (i) to continuation of the discount rate
or net price to existing customers during the Term and during any time
thereafter that FHC sells any Product as permitted hereunder, (ii) any sales
made pursuant to binding agreements between FHC and unaffiliated customers
entered into prior to the Effective Date, or (iii) to discounts beyond such
levels approved by Biosite.

 

(k)           Notwithstanding
anything to the contrary contained in this Agreement, but subject to Section
5(l), in the case where the [***] described in Schedule D (the “[***]”) is not purchased
but is instead leased by a FHC or Biosite customer over the term of the

 

 

***Confidential
Treatment Requested

 

19

 

customer’s written agreement (a “Reagent Rental
Agreement”), the following shall apply: (1) the Transfer Price paid to Biosite
by FHC for the [***] shall at all times during the course of this Agreement be [***];
(2) there shall be no GSMR with respect to such [***]; and (3) the provisions
of Sections 5(f)-(h) shall not apply.

 

(l)            Notwithstanding
anything to the contrary contained in this Agreement, in the case where the [***]
(as described in Schedule D) is not purchased but is instead leased by a FHC or
Biosite customer over the term of the customer’s written agreement (a “Reagent
Rental Agreement”), the following shall apply: (1) the Transfer Price paid to
Biosite by FHC for the [***] shall at all times during the course of this
Agreement be [***]; (2) there shall be no GSMR with respect to such [***]; and
(3) the provisions of Sections 5(f)-(h) shall not apply.

 

(m)          Notwithstanding
anything to the contrary contained in this Agreement, upon the expiration or
termination of this Agreement, Biosite shall pay to FHC the [***] for any [***]
or [***] under any and all Reagent Rental Agreements (as more particularly
described in Sections 5(k) and 5(l) above) obtained pursuant to this Agreement
or the Previous Distribution Agreements. For example, if a [***] is amortized
at a rate of [***] per month over a [***] Reagent Rental Agreement and the
customer pays this amount monthly together with (or as a part of) its purchase
of reagents or controls, if the Agreement expires or is terminated with [***]
remaining under the term of the Reagent Rental Agreement, then Biosite shall
pay to FHC [***].

 

(n)           No
later than [***] following the reduction of the GSMR of an [***] as provided in
Section 5(f)(i) or 5(f)(ii), FHC shall multiply the percentage difference in
the amount of the new and old GSMR by the [***] (as defined below) and the
resulting amount shall be split evenly between the parties. FHC shall determine
the [***] for each [***] by using the following formula:

 

(Actual
Selling Price of such [***] invoiced by FHC in the [***] calendar month of the
period with the new GSMR/number of units of such [***] invoiced by FHC in such
month) X Number of units of such [***] in FHC inventory as of the date
immediately prior to the change in GSMR causing this calculation

 

This calculation shall be done for each [***]
individually. For example, if such [***] is first sold to FHC by Biosite on
April 15, 2006, then no later than August 15, 2007, FHC shall
calculate the [***] as follows:

 

(Actual
Selling Price of such [***] Product invoiced by FHC in July 2007/number of
units of such [***] Product invoiced by FHC in July 2007) X Number of units of
such [***] Product in FHC inventory as of June 30, 2007

 

 

***Confidential
Treatment Requested

 

20

 

For the sake
of this example, FHC shall then multiply the [***] by [***] (the difference in
the GSMR between the [***] after the first sale of such Product by Biosite to
FHC and the [***]).

 

These provisions shall be
in addition to, and not in lieu of, Sections 5(g) and (h).

 

(o)           Biosite
shall provide FHC copies of each reagent rental agreement executed by Biosite
with a Contract Customer in accordance with the terms of Section 2(g) of this
Agreement as soon as practicable after execution by both Biosite and the
applicable Contract Customer.

 

(p)           Notwithstanding
anything to the contrary in this Agreement, the provisions of Sections 5(f)-(o)
shall apply exclusively to sales of Products [***], and the following
provisions shall apply exclusively to sales of Products in [***]. For the sake
of clarity, there shall be no GSMR for Products [***].

 

(i)            In
accordance with the payment terms set forth in Section 5(d) above, Biosite
shall receive payment of the [***] for Products shipped to FHC. Subject to the
provisions of Section 5(p)(iii) below, for each unit of Product sold by FHC and
its affiliates to unaffiliated customers in [***], should the [***] set forth
in Schedule L be [***] than the [***] for such Product unit, FHC is entitled to
a rebate from Biosite for such Product unit equal to the positive remainder of
the [***] set forth in Schedule L, for such Product unit.

 

(ii)           Subject
to the provisions of Section 5(p)(iii) below, for each unit of Product sold by
FHC and its affiliates to unaffiliated customers in [***], should the [***] be
less than the [***] Price set forth in Schedule L for such Product unit, FHC
will make an additional payment to Biosite for such Product unit equal to the [***]
set forth in Schedule L, less the [***], for such Product unit.

 

(iii)          Within
[***] after the end of each calendar month, FHC shall prepare and provide
Biosite with a reasonably detailed written sales report which shall (i) set
forth on a Product-by-Product basis the sales of Products by FHC and its
affiliates to unaffiliated customers in [***], and (ii) calculate on a
Product-by-Product basis the net amount (if any) of the additional payments
from FHC to Biosite and/or other rebates from Biosite to FHC owing under
Sections 5(p)(i) and 5(p)(ii) for such calendar month. Such sales reports are,
and shall remain the property of FHC, and shall be subject to Section 9 of this
Agreement, but may be used by Biosite solely for the purposes of performance of
its obligations and the exercise of its rights under this Agreement. Such
report shall be based on sales by FHC and its affiliates, as reflected on FHC’s
Key Supplier Report, on each Product during each calendar month. FHC shall pay
to Biosite any such additional payment, and Biosite shall pay to FHC any such
rebate, owing under Sections 5(p)(i) and 5(p)(ii) for each calendar month on or
before the later of the [***] day of the following calendar month or [***] days
after Biosite’s receipt of the applicable sales report for such calendar month.
Biosite and its agents

 

 

***Confidential
Treatment Requested

 

21

 

shall have the right, through an independent auditor
chosen by Biosite and reasonably acceptable to FHC, on reasonable notice and
not more than twice in each calendar year, to inspect and audit the relevant
books and records of FHC and any of its relevant affiliates to verify the
accuracy of such sales reports. Biosite shall pay the fees and expenses of such
audit.

 

(iv)          [***]
set forth in Schedule L shall be [***] on [***].

 

(q)           Current
[***] or [***] Customers. The following provisions apply to customers who have
purchased the [***] Products, other than the [***] (Catalog Number [***]) (the “[***]”),
or the [***] Products in the last six months of [***]. In addition to the
calculation set forth in Section 5(i) of the Agreement, within [***] after the
end of each calendar month, FHC shall prepare and provide Biosite with a
reasonably detailed written report which shall calculate the [***] for the [***]
Products and the [***] Products, for such calendar month, per customer. On or
before the due date for the payment described in Section 5(i) (if any) for such
calendar month, FHC shall pay Biosite [***] the increase in the [***] of the [***]
Products and the [***] Products from the [***], for such calendar month, per
customer calculated as follows:

 

(([***] – [***] Price) x number of units of such Product sold to such
customer) / 2

 

“[***]” shall be cumulative [***] Price for each such Product sold to a
customer in the last [***] months of [***]/ number of units sold to such
customer in the last [***] months of [***].

 

“[***]” shall be as follows:

 

(1)           for each [***]
Product: for each customer, the cumulative [***] Price for each [***] Product
sold to such customer during the specified period / number of such Products
sold to such customer during the specified period.

 

(2)           for each [***]
Product: for each customer, the cumulative [***] Price for each [***] Product
sold to such customer during the specified period / number of Products sold to
such customer during the specified period.

 

The calculations shall be done on customer-by-customer and
product-by-product basis with each customer having its own [***] Price and [***]
Price. Notwithstanding anything to the contrary contained in this Agreement,
through the remainder of the Term and during any time thereafter that FHC sells
any Product as permitted hereunder, for [***] Products and [***] Products only,
for the purposes of calculating the [***] of the Agreement, the [***] Price for
any customer shall be deemed to be the lower of (i) the [***] Price for such
customer, and (ii) the [***] Price for such customer. This provision shall
survive the expiration or termination of the Agreement to allow for the
calculation regarding the final month of the Agreement.

 

 

***Confidential
Treatment Requested

 

22

 

(r)            New
[***] or [***] Customers. The following provisions apply to customers who have
not purchased [***] Products or [***] Products in the last [***] months of [***]
(“[***] or [***] Customers”). In addition to the calculation set forth in
Section 5(i) of the Agreement, within [***] after the end of each calendar
month, FHC shall prepare and provide Biosite with a reasonably detailed written
report which shall calculate the [***] Price for the [***] and the [***]
Products for such calendar month, per customer. On or before the due date for
the payment described in Section 5(i) (if any) for such calendar month, FHC
shall pay Biosite [***] of the [***] Price, for such calendar month, per
customer calculated as follows:

 

([***] Price x [***]%) / [***]

 

“[***] Price” shall be as follows:

 

(1)           for each [***]
Product: for each customer, the cumulative [***] Price for each [***] Product
sold to such customer during the specified period.

 

(2)           for each [***]
Products: for each customer, the cumulative [***] Price for each [***] Product
sold to such customer during the specified period.

 

A customer may be a New [***] or [***] Customer for the purposes of
only one category of Products ([***] Products or [***] Products). The
calculations shall be done on a customer-by-customer and product-by-product
basis with each customer having its own [***] Price. Notwithstanding anything
to the contrary contained in this Agreement, through the remainder of the Term
and during any time thereafter that FHC sells any Product as permitted
hereunder, for New [***] Products or [***] Products Customers, for the purposes
of calculating the [***] of the Agreement, the [***] Price for any customer
shall be deemed to be [***] of the [***] Price for such customer. This
provision shall survive the expiration or termination of the Agreement to allow
for the calculation regarding the final month of the Agreement.

 

(s)           Notwithstanding
anything to the contrary, Biosite shall be responsible for all rebates that it
offers or otherwise provides to any customers, including Contract Customers,
through its contracts, directly or indirectly, including GPO arrangements.

 

6.             Term
and Termination.

 

(a)           This
Agreement shall commence on the Effective Date and shall terminate on December
31, 2008 (the “Initial Term”). Except as otherwise set forth in this Agreement,
(i) unless either party (in such party’s sole discretion) gives to the other
party notice of non-renewal not less than [***] prior to the expiration of the
Initial Term, this Agreement automatically shall be extended for a period of
one (1) year following the expiration of the Initial Term (the “First Extended
Term”), and (ii) unless either party (in such party’s sole discretion) gives to
the other party notice of non-renewal not less than [***] prior to the
expiration of the First Extended Term, this Agreement automatically shall be
extended for a period of one

 

 

***Confidential
Treatment Requested

 

23

 

(1) year following the expiration of the First
Extended Term (the “Second Extended Term”); provided, however, if FHC exercises
its right to opt out of the requirements of Section 3(b)(i), then this
Agreement thereafter may not be further extended (subject to
Section 2(g)(vi)). The First Extended Term and the Second Extended Term
(if any), collectively, shall be referred to as the “Extended Term”. The
Initial Term and the Extended Term, collectively, shall be referred to as the “Term”.
Notwithstanding anything to the contrary contained in this Agreement, FHC may
terminate this Agreement upon written notice to Biosite in the event that, in
the case of Roche Diagnostics Corporation, et al., v. Biosite Incorporated,
Case No: 1:04-CV-01848-LJM-VSS (or any ancillary or related litigation), Roche
Diagnostics Corporation (or any other plaintiff in any ancillary or related
litigation) is issued a preliminary or permanent injunction against Biosite
with respect to the distribution of one or more of the Products, which
injunction remains undismissed or unstayed for a period of not less than
thirty (30) days, and in the event of such termination FHC shall cooperate
with Biosite, and take such action as reasonably requested by Biosite, to
facilitate a prompt and orderly transition to Biosite (or its designee) of all
customer accounts regarding sales of Products to the extent possible, provided
that the foregoing shall in no way limit FHC’s ability to promote, market,
advertise, distribute or sell products (including products competitive to the
Products) to all such customers following such termination.

 

(i)            In
the event that Fisher Scientific International Inc., or one of its subsidiaries
(either direct or indirect subsidiaries) acquires, whether through merger,
asset purchase or otherwise, an entity or business operation that manufactures,
promotes, markets, advertises, distributes or sells one or more products that
compete with one or more of the Products, then FHC shall provide notice to
Biosite of such transaction (a) within five (5) business days of the public
disclosure of such transaction or (b) if there is no public disclosure, within
ten (10) business days from the execution of a definitive agreement for the
applicable transaction. The parties shall then promptly discuss the
implications of such transaction. At such meeting, the parties shall discuss
FHC’s intentions with respect to the distribution of the competitive product(s).
In the event that FHC intends to distribute one or more of the competitive
products in the Territory or in the event that FHC provides Biosite with a
notice pursuant to Section 3(b)(iii) of its intention to promote, market,
advertise, distribute or sell a competitive product that is manufactured by an
affiliate, then upon written notice by Biosite (at the option of Biosite in its
sole discretion) delivered to FHC within fifteen (15) days after such
meeting, Biosite may, in its sole discretion, elect to (a) make no change with
respect to the Agreement, or (b) have the distributorship immediately become
non-exclusive and Biosite shall have the right to promote, market, advertise,
distribute and sell Products direct to any customer or to enter into one or
more distribution agreements with any third party (without restriction or
obligation to FHC). In the event that Biosite elects to make the
distributorship non-exclusive, at any time thereafter either party shall have
the right to terminate this Agreement on [***] prior written notice to the
other party.

 

(ii) 
For the sake of clarity, in the event that Biosite elects to (a) have
the distributorship become non-exclusive as provided in Section 6(a)(i) above
or (b) terminate the Agreement as provided in Section 6(a)(i) above, during
such [***] period, FHC shall have the right to promote, market, advertise,
distribute and sell products that are competitive with the Products, including
without limitation the products that are manufactured by an affiliate of FHC
that are competitive with the Products.

 

 

***Confidential
Treatment Requested

 

24

 

(b)           This
Agreement may be terminated by a party, in the event the other party materially
breaches its obligations hereunder and should fail to remedy such material
breach within thirty (30) calendar days after receiving written notice of such
material breach.

 

(c)           The
rights and duties of each party under Sections 2(g)(vi), 3(a) to the
extent such section provides for obligations after the Term, 3(d), 3(f), 3(g),
4(k), 4(l), 6(c), 7, 8, 9, 10, 14, 15, 19, 24 and 25 of this Agreement and
Biosite’s obligations under the Continuing Guaranty as referred to in
Section 10(a) hereof and attached hereto as Schedule A, shall survive
termination of this Agreement and be enforceable in accordance with their terms.
Upon any termination of this Agreement, the parties shall mutually agree upon a
message (the “Message”) to be conveyed to all third parties concerning such
termination of this Agreement and neither party shall make any statement (oral
or written) relating to the parties’ relationship under this Agreement or
pertaining to the termination of this Agreement inconsistent with such mutually
agreed Message, except as otherwise required by law, regulation or court order
(provided that the party making such statement shall give the other party
reasonable notice of any such required statement and shall give the other party
an opportunity to object to any such statement or to request confidential
treatment therefor) or as necessary to enforce its rights under this Agreement.
Additionally, FHC shall not make any statement regarding any Product after the
termination of this Agreement that is not expressly permitted in the Message. Notwithstanding
the preceding provisions of this Section 6(c), at all times after
termination or expiration of this Agreement, (i) FHC shall have the right
to create marketing materials that describe the attributes of the Products
versus the attributes of third party products (provided that such information
regarding the Products shall be based solely on publicly available information
regarding the Products and not based on information obtained by FHC, or based
on the parties’ relationship, under this Agreement or any prior written
agreement between the parties), provided that FHC shall not take any action
that would interfere with Biosite’s efforts to develop and maintain the
reputation of and goodwill with respect to the Products, and (ii) Biosite
shall have the right to communicate with Contract Customers for purposes of
ordinary course of business customer support and regarding the status of
delivery of their purchase commitments or agreements after the termination of
this Agreement, provided that Biosite shall not take any action that would
interfere with FHC’s efforts to develop and maintain its reputation and
goodwill. The parties acknowledge that Biosite’s comparisons of its products
(including the Products) to any other products shall not constitute
interference with FHC’s efforts to develop and maintain its reputation and
goodwill.

 

(d)           IN
NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY CONTINGENT,
INCIDENTAL, OR CONSEQUENTIAL DAMAGES OF THE OTHER PARTY, OR ANY LOSS OF PROFITS
OR REVENUE OF THE OTHER PARTY, WHETHER ARISING IN CONTRACT, TORT (INCLUDING
NEGLIGENCE), WARRANTY, STRICT LIABILITY OR OTHERWISE.

 

(e)           Subject
to the following sentence, in no event shall either party, directly or
indirectly, initiate or prosecute, or assist or induce any third party to
initiate or prosecute (other than as required under court order or legal
process such as a subpoena), any claim, demand, suit, action, cause of action
or other adversary proceeding relating to or arising out of this Agreement

 

25

 

or the subject matter of this Agreement, other than a
claim, demand, suit, action, cause of action or other adversary proceeding to
the extent alleging (1) a material breach of express contract under this
Agreement (provided that if the alleged material breach is curable, (i) the
non-breaching party has given written notice of such material breach and the
breaching party has failed to remedy such material breach within thirty (30)
days and (ii) during such thirty (30) day cure period, at the request of the
party allegedly in breach, the parties shall meet and confer in good faith to
discuss the grounds of the alleged breach), or (2) defamation through a
statement made with “knowledge that it was false or with reckless disregard of
whether it was false or not” by one party of the other. Nothing in this
Section 6(e) shall in any way limit any claim, demand, suit, action, cause
of action or other proceeding (i) that a party (“Asserting Party”) may
have against the other party to the extent relating to or arising as a result
of a third party claim, demand, suit, action, cause of action or other
proceeding against the Asserting Party, provided that the Asserting Party can
provide written evidence of such claim, demand, suit, action, cause of action
or other proceeding by such third party or (ii) that a party may have
against a third party relating to a Product.

 

7.             Trademarks.

 

(a)           Subject
to the terms and conditions of this Agreement, Biosite hereby grants to FHC a
nonexclusive, nontransferable, license during the Term and during any time
thereafter that FHC sells any Product as permitted hereunder, without the right
to sublicense, to use the trademarks (including, but not limited to the
trademark “Triage”) and tradenames (including, but not limited to “Biosite
Incorporated” and “Biosite”) relating to the Products (collectively, the “Biosite
Marks”) solely for the purpose of promoting, marketing, selling, and
distributing the Products.

 

(b)           All
right, title, and interest in and to the Biosite Marks shall remain with
Biosite. During the Term and thereafter, FHC will not contest Biosite’s
exclusive right, title and interest in and to, or the validity of, the Biosite
Marks. In addition, FHC will not in any manner represent that it has any
interest in the Biosite Marks, except for the limited license provided herein. Use
of the Biosite Marks by FHC shall inure to the sole benefit of and be on behalf
of Biosite.

 

(c)           All
Product units sold by Biosite to FHC will bear one or more of the Biosite
Marks, and FHC shall not alter, remove or modify the Biosite Marks, nor affix
any other trademark to the Product, without the prior express written consent
of Biosite. FHC shall not utilize any of the Biosite Marks in connection with
any promotional brochures or advertising materials relating to the Products
without the prior express written consent of Biosite, which consent shall not
be unreasonably withheld, delayed or conditioned. Biosite’s consent to the use
of the Biosite Marks shall be conditioned upon such brochure or advertising
materials clearly indicating Biosite’s ownership of the Biosite Marks.

 

(d)           All
Product units purchased by FHC hereunder shall be marketed by it in the
original packages under the original labels provided by Biosite, and FHC shall
make no modifications, or alterations to such Product units or labels;
provided, however, that FHC may affix labels or other indices which serve to
identify FHC as a distributor of the Product, so long as they do not cover and
are not inconsistent with any of Biosite’s Product labels or markings.

 

26

 

(e)           Nothing
in this Agreement shall be construed as granting FHC any ownership interest in
the Biosite Marks, and FHC acknowledges that it has been advised by Biosite of
Biosite’s claim of ownership of the Biosite Marks. FHC agrees that it will do
nothing inconsistent with such ownership. Specifically, FHC agrees that: it
will not challenge the validity of, or Biosite’s ownership of, any of the
Biosite Marks; it will not take any action that is inconsistent with, or may
impair, Biosite’s right, title and interest to the Biosite Marks; it will not
represent to any third party that it has any ownership interest in the Biosite
Marks; and it will execute and deliver to Biosite any and all documents which
Biosite may request to confirm in Biosite all right, title and interest in the Biosite
Marks.

 

(f)            FHC
shall make no statement to the press relating or referring to the Products
without the prior express written approval of Biosite, which shall not be
unreasonably withheld. Notwithstanding the foregoing, solely to the extent
required by applicable law, FHC shall have the right to make a statement to the
press relating or referring to the Products without the prior express written
approval of Biosite, provided that FHC gives Biosite prompt written notice and
together with a copy of such statement.

 

(g)           Either
party shall promptly notify the other in writing of any challenges to the
validity, infringement on or unauthorized use of any of the Biosite Marks,
actual or threatened, that may come to such party’s attention. Biosite shall be
responsible for and shall assume all expenses of the enforcement of the Biosite
Marks.

 

(h)           Biosite
recognizes that FHC is the owner of the trademarks and trade names denoting FHC
or FHC products (collectively, the “FHC Marks”), which FHC may elect to use in
the promotion and sale of the Products, and that Biosite has no right or
interest in such FHC Marks; provided, however, that except as otherwise set
forth in Section 7(b) hereof, no FHC labels, package inserts or other material
shall accompany the Products without the prior express written approval of
Biosite.

 

(i)            Biosite
shall not utilize any FHC Marks in connection with any promotional brochures or
advertising materials relating to the Products, or otherwise, without the prior
express written consent of FHC. FHC’s consent to the use of the FHC Marks shall
be conditioned upon such brochure or advertising materials clearly indicating
FHC’s ownership of the FHC Marks. Nothing in this Agreement shall be construed
as granting Biosite any license or ownership or other interest in the FHC
Marks, and Biosite acknowledges that it has been advised by FHC of FHC’s claim
of ownership of FHC’s Marks. Biosite agrees that it will do nothing
inconsistent with such ownership and that all use of the FHC Marks will inure
to the benefit of and be on behalf of FHC. Specifically, Biosite agrees that:
it will not challenge the validity of, or FHC’s ownership of, any of the FHC
Marks; it will not take any action that is inconsistent with, or may impair,
FHC’s right, title and interest to the FHC Marks; it will not represent to any
third party that it has any ownership interest in the FHC Marks; and it will
execute and deliver to FHC any and all documents which FHC may request to
confirm in FHC all right, title and interest in the FHC Marks.

 

(j)            Upon
termination of this Agreement, FHC shall continue to be entitled to utilize the
Biosite Marks on the terms agreed to previously by the parties in connection
with FHC’s promotion, marketing, distribution and sale of units of Products as
provided in this 

 

27

 

Agreement, or remaining in FHC’s inventory and not
repurchased by Biosite. Thereafter, except as herein provided, FHC shall
terminate all use of Biosite Marks, and shall at Biosite’s request and at
Biosite’s expense, destroy or return to Biosite all literature and other
advertising and promotional materials bearing only the Biosite Marks. Notwithstanding
the foregoing, FHC shall not be required to destroy its inventory of catalogs
and other materials that include a reference to Biosite Products among other
FHC distributed products and FHC shall be allowed to use all such materials in
its business until same are depleted or revised. In the event of termination or
expiration of this Agreement, FHC agrees to cooperate with Biosite and to
execute any and all documents requested by Biosite for the purpose of canceling
any registered user or other rights with respect to Biosite’s name and the
Biosite Marks that FHC may have acquired in operating hereunder, or, at Biosite’s
election, in transferring such rights to Biosite or its FHC designee. FHC also
agrees to cooperate with Biosite in transferring any appropriate rights in
connection with the Biosite Marks to Biosite and/or Biosite’s designee, at
Biosite’s sole cost and expense, if Biosite desires to sell or have sold
products in the Territory and Physician Office Practices (other than the
Products) other than by FHC.

 

8.             Copyrights.

 

(a)           FHC
hereby acknowledges that Biosite may claim copyright protection with respect to
its package inserts and other supporting materials which it includes with each
of the Product units, and FHC further acknowledges the validity of Biosite’s
right to claim the copyright protection to such materials. FHC further acknowledges
that Biosite has advised FHC that it has the sole and exclusive right to claim
the copyright protection with respect to all of its package inserts and other
supporting materials included with the Products, and FHC shall take no action
which is in any way inconsistent with Biosite’s claim of copyright protection
that it expects to make with respect to such materials.

 

(b)           In
order to protect against infringement of Biosite’s copyright through
unauthorized reproduction or duplication of its copyrighted materials, such
materials included with the units of Products sold by Biosite to FHC shall bear
appropriate copyright markings. Nothing contained in this Section 8 shall
prohibit FHC from copying and distributing to its sales representatives Product
advertising, literature and other materials prepared by or on behalf of Biosite
for the purpose of fulfilling FHC’s obligations under this Agreement.

 

(c)           Either
party shall promptly notify the other in writing of any infringements, whether
within or without the Territory and Physician Office Practices, of any of
Biosite’s copyrights which come to the attention of such party. FHC shall, at
the request of Biosite, provide Biosite with all reasonable assistance in
initiating and prosecuting any legal action against any infringer of Biosite’s
copyrights within the Territory and Physician Office Practices; provided,
however, that all costs incurred in connection with any such copyright
infringement action shall be borne solely by Biosite.

 

9.             Trade
Secrets and Confidential Information.

 

(a)           FHC may
receive various trade secrets of Biosite and other information of Biosite (and
in each such instance, at the time of disclosure to FHC, Biosite shall provide
FHC with written notice that Biosite considers such information to be a trade
secret or otherwise 

 

28

 

confidential) of a confidential nature (including but not limited to
specific technical information concerning the Products). FHC agrees that it
will not disclose to anyone, directly or indirectly, any of such confidential
information, or use such confidential information other than as reasonably
required in the course of its performance of its obligations and the exercise
of its rights under this Agreement. Notwithstanding the foregoing, FHC may
disclose such confidential information to the extent required by applicable
law, regulation or court order, provided that FHC shall give Biosite reasonable
notice of any such required disclosure and shall give Biosite an opportunity to
object to any such disclosure or to request confidential treatment thereof. FHC
shall, at Biosite’s option, return such information to Biosite or destroy all
such data having physical form and all copies thereof. The obligations set
forth in this Section 9(a) shall survive any termination of this Agreement for
a period of [***].

 

(b)           Biosite
may receive various trade secrets of FHC and other information of FHC of a
confidential nature. Biosite agrees that it will not disclose to anyone,
directly or indirectly, any of such trade secrets or other confidential
information, or use such trade secrets or other confidential information other
than as reasonably required in the course of its performance of its obligations
and the exercise of its rights under this Agreement. Notwithstanding the
foregoing, Biosite may disclose such trade secrets or other confidential
information to the extent required by applicable law, regulation or court
order, provided that Biosite shall give FHC reasonable notice of any such
required disclosure and shall give FHC an opportunity to object to any such
disclosure or to request confidential treatment thereof. Biosite shall, at FHC’s
option, return such information to FHC or destroy all such data having physical
form and all copies thereof. The obligations set forth in this Section 9(b)
shall survive any termination of this Agreement for a period of [***].

 

(c)           Notwithstanding
any provision set forth in this Section 9 to the contrary, the parties’
obligations under this Section 9 shall not apply to the extent that: (i) the
confidential information, or any relevant part of it, can be shown to be in the
public domain prior to the date of this Agreement; (ii) the confidential
information, or any relevant part of it, becomes part of the public domain,
other than by some unauthorized act or omission, after the date hereof; (iii)
the confidential information, or any relevant part of it, is disclosed to such
party by a third party who has the right to make such disclosure; (iv) express
written permission to disclose the confidential information, or any relevant
part of it, or to make use of same, is obtained from the non-disclosing party
by the disclosing party; or (v) the information is developed independently of
the confidential information by the other party based on written records
maintained in the ordinary course.

 

(d)           Notwithstanding
anything to the contrary, [***] and [***] provided to Biosite by FHC (whether
under this Agreement or a prior agreement between the parties), including but
not limited to the information provided to Biosite under [***], shall be
jointly owned by both parties and shall not be subject to the terms and
conditions set forth in Sections 9(a) or 9(b). Such [***] and [***] information
may be used by either party for any lawful purpose, subject to the following
restrictions: (i) Biosite shall not disclose sales [***] or [***] information
disclosed to Biosite by FHC under this Agreement (or calculated by Biosite
using information disclosed to Biosite by FHC under this Agreement) to any
third party (excluding Biosite’s attorneys, accountants, or as may be required
by applicable law, regulation or court order or as permitted

 

 

***Confidential
Treatment Requested

 

29

 

under clauses (i) through (v) under Section 9(c)
above); and (ii) Biosite shall not disclose any [***] or [***] disclosed to
Biosite by FHC under this Agreement to [***], [***] or [***] (unless so
required by applicable law, regulation or court order or as permitted under
clauses (i) through (v) under Section 9(c) above). The terms and conditions of
this Section 9(d) shall supersede any inconsistent terms and conditions that
may appear in a prior agreement between the parties if the terms and conditions
of any such prior agreement survive termination of such prior agreement.

 

10.           Biosite’s
Warranties: Disclaimer of Warranties.

 

(a)           Biosite
agrees that it shall execute and warrants that it shall abide by the terms of
FHC’s Continuing Guaranty, a copy of which is attached hereto as Schedule A and
which guaranty is incorporated herein by reference. The terms and provisions of
the Continuing Guaranty shall survive the termination of this Agreement. Prior
to the first shipment of Product to FHC, Biosite shall provide FHC with
certificates of insurance which meet the requirements of paragraph D of the
Continuing Guaranty. Biosite’s insurance carriers shall at all times during the
Term be rated by Best’s as B+ or superior. Biosite is not aware after due
inquiry of any circumstance which would prevent the issuance of such policy.

 

(b)           In
addition to the warranties of Biosite set forth in this Agreement and in the
Continuing Guaranty, Biosite warrants that each of the Products will conform to
the specifications set forth in Product literature prepared by or on behalf of
Biosite and that the Products will comply and be manufactured, packaged,
sterilized (if applicable), labeled and shipped in compliance with all
applicable federal, state and local laws, orders, regulations and standards. Biosite
further warrants that the Products do not infringe upon the intellectual
property rights of any third party.

 

(c)           Biosite
and FHC shall extend to customers only the Product Warranty embodied in
Schedule I hereto; provided that Biosite may modify such Product Warranty with
FHC’s consent, which consent shall not be unreasonably withheld. Biosite shall
not modify or amend the warranty during the Term without providing FHC with
sixty (60) days, prior written notice. Biosite warrants and represents that the
Products will perform in accordance with Biosite’s warranty.

 

(d)           Except
for the warranties described in Sections 10 (a)-(c) hereof, all of which shall
inure to the benefit of, and shall be enforceable by, FHC’s customers, Biosite
MAKES NO WARRANTIES TO CUSTOMERS AND FHC SHALL NOT MAKE ANY OTHER WARRANTIES TO
CUSTOMERS AS TO THE MERCHANTABILITY OR FITNESS OF THE PRODUCT FOR A PARTICULAR
USE.

 

11.           Force
Majeure.

 

The obligations of either party to perform under this Agreement shall
be excused during each period of delay to the extent caused by such matters as
strikes, shortages of power or raw materials, government orders or acts of God,
which are reasonably beyond the control of the party obligated to perform. The
affected party shall make all commercially reasonable efforts to remedy the
effects of such force majeure. Any force majeure event shall not excuse
performance

 

 

***Confidential
Treatment Requested

 

30

 

by the party but shall delay performance, unless such force majeure
continues for a period in excess of ninety (90) days. In such event, the party
seeking performance may cancel its obligations hereunder.

 

12.           Notices.

 

Any notice required by this Agreement shall be in writing, and may be
delivered in person, by nationally recognized overnight delivery service or by
any lawful means to the party for whom intended at its address set forth below,
and shall be effective on receipt.

 

	
  If to Biosite:

  	
   

  	
  Biosite Incorporated

  
	
   

  	
   

  	
  9975 Summers Ridge Road

  
	
   

  	
   

  	
  San Diego, California 92121

  
	
   

  	
   

  	
  Telecopy: (858) 695-9853

  
	
   

  	
   

  	
  Attn: Tom Watlington

  
	
   

  	
   

  	
   

  
	
  with a copy to:

  	
   

  	
  Morrison & Foerster LLP

  
	
   

  	
   

  	
  3811Valley Centre Drive, Suite 500

  
	
   

  	
   

  	
  San Diego, California 92130

  
	
   

  	
   

  	
  Telecopy: (858) 523-2827

  
	
   

  	
   

  	
  Attn: Mark R. Wicker, Esq.

  
	
   

  	
   

  	
   

  
	
  If to FHC:

  	
   

  	
  Fisher HealthCare

  
	
   

  	
   

  	
  9999 Veterans Memorial Drive

  
	
   

  	
   

  	
  Houston, Texas 77038

  
	
   

  	
   

  	
  Telecopy: (281) 878-2293

  
	
   

  	
   

  	
  Attn: General Counsel

  
	
   

  	
   

  	
   

  
	
  with a copy to:

  	
   

  	
  Fisher Scientific International Inc.

  
	
   

  	
   

  	
  Liberty Lane

  
	
   

  	
   

  	
  Hampton, New Hampshire 03842

  
	
   

  	
   

  	
  Telecopy: (603) 929-2703

  
	
   

  	
   

  	
  Attn: General Counsel

  

 

or such other address as provided in writing
in the manner provided by this Section 12.

 

13.           Entire
Agreement.

 

This Agreement, including Schedules and Exhibits, constitutes the
entire agreement between the parties relating to the subject matter hereof and
supersedes all prior agreements, understandings and representations, whether
written or oral, between the parties with respect to such subject matter. In
ordering and delivery of the Products, the parties may employ their standard
forms, but nothing in those forms shall be construed to modify or amend the
terms of this Agreement.

 

31

 

14.           Attorneys’
Fees.

 

In the event any claim or counterclaim is asserted or action is
commenced to enforce any of the rights or obligations of the parties under this
Agreement, the prevailing party shall be entitled to collect from the other
party, as part of the judgment rendered with respect to such claim or action,
reasonable attorneys’ fees, expenses and court costs.

 

15.           Governing
Law.

 

THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH
THE LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD TO CALIFORNIA CHOICE OF LAW
PROVISIONS.

 

16.           Compliance
With Applicable Laws.

 

In connection with the sale of the Products hereunder, Biosite and FHC
shall comply with all applicable laws, regulations and orders of governmental
bodies having jurisdiction in respect of activities contemplated by or covered
under this Agreement, including without limitation, obtaining all necessary
permits, licenses and regulations. FHC shall cooperate fully with Biosite, at
Biosite’s sole cost and expense, in connection with securing and maintaining
any governmental registration or other governmental permits required with
respect to marketing the Products in the Territory and Physician Office
Practices and FHC will notify Biosite of any local laws affecting the Products
which may come to its attention.

 

17.           Assignment.

 

(a)           Subject
to Sections 2(h) and 17(b), neither party shall assign or transfer this
Agreement, by operation of law or otherwise, in whole or in part without the
prior written consent of the other party in each and every instance, which
consent may not be unreasonably withheld. If either party wishes to assign or
otherwise transfer this Agreement, as aforesaid, in each instance the party
seeking to assign or otherwise transfer this Agreement shall submit to the
other party for such party’s review and approval as soon as practicable such
information as the other party may reasonably request concerning the assignee
or transferee and the party from which consent is sought shall have thirty (30)
days following receipt of the fully responsive materials in which to review the
same and approve or reject the assignment or transfer. In any event in which
the party from which consent is sought reasonably rejects the assignment or
transfer, this Agreement shall terminate [***] following the date on which the
rejection is received by the party seeking to assign or transfer. The parties
shall make best efforts to promptly and amicably wind up all outstanding
matters concerning the subject matter of this Agreement.

 

(b)           Notwithstanding
Section 17(a) above: (i) a merger, reorganization, recapitalization, sale or
transfer of all or substantially all of the assets, change of control, or
similar transaction of a party shall not be deemed an assignment or transfer of
this Agreement subject to the provisions of Section 17(a) above, and (ii) FHC shall
be entitled to assign this Agreement to an entity with which it is affiliated
(by reason of greater than fifty percent (50%) ownership of the voting
securities thereof), without the prior written consent of Biosite, but upon
prior written notice to Biosite.

 

 

***Confidential
Treatment Requested

 

32

 

18.           Amendments.

 

No amendment or modification of the terms of this Agreement shall be
binding on either party unless reduced to writing and signed by an authorized
officer of the party to be bound.

 

19.           Existing
Obligations.

 

Each party represents and warrants that the terms of this Agreement do
not violate any existing obligations or contracts of it. Each party shall
defend, indemnify and hold harmless the other party from and against any and
all claims, demands, liabilities and causes of action that are hereafter made
or brought against the other party that allege any such violation.

 

20.           Relationship
of the Parties.

 

(a)           For
the purposes of this Agreement, FHC and Biosite are deemed to be independent
contractors and not the agent or employee of the other. Neither FHC nor Biosite
shall have the authority to make any statements, representations or commitments
of any kind, or take any action, which shall be binding on the other, except as
provided for herein or authorized in writing by the party to be bound.

 

(b)           This
Agreement does not grant any license from Biosite to FHC or from FHC to Biosite
except as expressly provided herein.

 

21.           Successors
and Assigns.

 

This Agreement shall inure to the benefit of and be binding upon the
parties hereto and their respective successors and permitted assigns.

 

22.           Counterparts.

 

This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original for all purposes.

 

23.           Approvals
and Consents.

 

Each of the parties represents to the other that all necessary
approvals of any third persons, the granting of which are necessary for the
consummation of the transactions contemplated hereby, or for preventing the
termination of any right, privilege, license or agreement or any right granted
hereunder have been received by both parties to this Agreement.

 

24.           Miscellaneous.

 

Any payment obligation under this Agreement which shall be due from
Biosite to FHC and for which no date of payment is specified in this Agreement
shall be payable on the thirtieth (30th) day following the day on which the
event occurs which triggers Biosite’s obligation to make any such payment.

 

33

 

25.                                 Further
Assurances.

 

Biosite and FHC each shall perform any
and all further acts and execute and deliver any and all further documents and
instruments that may be reasonably necessary to carry out the provisions
of this Agreement.

 

26.                                 Non-Solicitation.

 

During the term of this Agreement and for a
one year period thereafter, neither party shall solicit for employment, or
hire, the other party’s employees without the prior written consent of the
other party.

 

27.                                 Relationship
Summits.

 

Twice per year during the Term (or more or
less frequently as the parties mutually determine), duly authorized
representatives of each party shall meet and in good faith discuss the
relationship of the parties. Discussions at such “relationship summits” may include
but not be limited to marketing tactics and strategies and business growth
plans for the Products.

 

28.                                 2004
Distribution Agreement.

 

The parties acknowledge and agree that the
2004 Distribution Agreement shall terminate simultaneously with the
effectiveness of this Agreement and that all rights and obligations of the
parties during the term of the 2004 Distribution Agreement shall be governed by
the terms thereof.

 

IN WITNESS WHEREOF, the parties have, by
their duly authorized officers, executed this Agreement on the date first set
forth above.

 

	
  BIOSITE
  INCORPORATED

  	
  FISHER
  SCIENTIFIC COMPANY L.L.C.

  
	
   

  	
   

  
	
  By:

  	
   /s/ Tom
  Watlington

  	
   

  	
  By:

  	
     /s/  Kirk
  Kimler          

  	
   

  
	
   

  	
   

  
	
  Title:

  	
    Executive
  VP/ COO

  	
   

  	
  Title:

  	
   President
  and GM

  	
   

  
								

 

34

 

SCHEDULE 2(e)(iv)

 

Customers who have made at
least one purchase directly from Biosite in 2005.

 

	
  Cust #

  	
   

  	
  Cust Name

  	
   

  	
  City

  	
   

  	
  State

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

35

 

	
  Cust #

  	
   

  	
  Cust Name

  	
   

  	
  City

  	
   

  	
  State

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

36

 

SCHEDULE 3(b)(iii)

 

	
  Product

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

	
  Product

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

[***]

 

	
  Product

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

[***]

 

***Confidential Treatment Requested

 

37

 

SCHEDULE A

 

CONTINUING
GUARANTY

 

A.                                   Biosite Incorporated (hereinafter referred to
as “Seller”), having its principal office and place of business at 11030
Roselle, Ste. D, San Diego, California 92121, hereby guarantees that all
Products (including their packaging, labeling and shipping) comprising each
shipment or other delivery hereinafter made by Seller (hereinafter referred to
as “Products”) to or on the order of Fisher Scientific Company L.L.C., a
Delaware limited liability company, having its principal place of business at
2000 Park Lane, Pittsburgh, Pennsylvania 15275, or to any of its branches,
divisions, subsidiaries, affiliates, or any of their customers (hereinafter collectively
referred to as “Fisher”), pursuant to that certain Distribution Agreement
effective as of July __, 2005 (the “Distribution Agreement”), between
Seller and Fisher Scientific Company L.L.C., a Delaware limited liability
company represented by its Fisher HealthCare division, are, as of the date of
such shipment or delivery, in compliance with applicable federal, state and
local laws, and any regulations, rules, declarations, interpretations and
orders issued thereunder, including, without limitation, the Federal Food, Drug
and Cosmetic Act, as amended, and conform to representations and
warranties made by Seller in its advertising, product labeling and literature.

 

B.                                     Further, with respect to any Product that is
privately labeled for Fisher, if any, Seller agrees to make no change in such
Products or the Fisher artwork on the labeling or packaging relating thereto
without first obtaining the written consent of Fisher. Seller recognizes that
Fisher is the owner of the trademarks and trade names connoting Fisher which it
may elect to use in the promotion and sale of such private label Products
and that Seller has no right or interest in such trademarks or trade names.
Seller shall periodically analyze and review packaging and labeling for any
Products which are private labeled for Fisher to ensure conformity with the
provisions of paragraph A hereof and the adequacy of Product warnings and
instructions.

 

C.                                     Seller hereby agrees that it will reimburse
Fisher Scientific Company L.L.C., a Delaware limited liability company, for all
reasonable out-of-pocket costs and expenses incurred in connection with any
product corrective action or recall relating to the Products which is requested
by Seller or required by any governmental entity.

 

D.                                    Seller agrees to procure and maintain product
liability insurance with respect to the Products and contractual liability
coverage relating to this Guaranty, with insurer(s) having Best’s rating(s) of
A- or better, naming Fisher as an additional insured (Broad Form Vendors
Endorsement), with minimum limits in each case of [***]. Seller shall promptly
furnish to Fisher Scientific Company L.L.C., a Delaware limited liability
company, a certificate of insurance and renewal certificates of insurance
evidencing the foregoing coverages and limits. The insurance shall not be
canceled, reduced or otherwise changed without providing Fisher with at least
ten (10) days prior written notice.

 

E.                                      Subject to the provisions of Section 4(l)
of the Distribution Agreement, Seller agrees to and shall protect, defend,
indemnify and hold harmless Fisher Scientific Company L.L.C., a Delaware
limited liability company, (and with respect to Subparagraph E.(i) below,
the customers of Fisher Scientific Company L.L.C., a Delaware limited liability
company) from any and all claims, actions, costs, expenses and damages,
including reasonable attorney’s fees and expenses arising out of: (i) any
actual or alleged patent, trademark or copyright infringement in the design,
composition, use, sale, advertising or packaging of the Products; (ii) any
breach of the representations or warranties set forth in this Guaranty; (iii) the
sale or use of the Products where such liability results from the act or
omission of Seller (whether for breach of warranty, strict liability in tort,
negligence or otherwise). In each such case, Fisher shall give Seller prompt
written notice of any such claim, shall permit Seller to assume sole control of
the defense thereof and shall provide all reasonable assistance in connection
with the defense of such claim. Fisher shall have the right to retain its own
counsel and to participate in such defense, with the fees and expenses of such
counsel to be paid by Seller, if representation of Fisher by counsel retained
by Seller would be inappropriate due to actual differing interests between
Fisher and any other party represented by such counsel in such proceeding.

 

F.                                      Seller agrees to and shall provide to Fisher
Material Safety Data Sheets and other information concerning any Product as
required by then applicable federal, state or local law.

 

***Confidential Treatment Requested

 

38

 

G.                                     Seller agrees to and shall accept, at its
facility, all of Fisher’s unsold or expired Products containing hazardous chemicals,
materials or substances for disposal, recycling or use. Fisher shall be
responsible for packing and transportation costs to Seller. Seller shall be
responsible for all other costs, including, without limitation, any costs
associated with Seller’s disposal, recycling or use.

 

H.                                    If the Products to be furnished by Seller are
to be used in the performance of a U.S. government contract or subcontract,
those clauses of the applicable U.S. Government procurement regulation which
are mandatorily required by Federal Statute to be included in U.S. Government
subcontracts shall be incorporated herein by reference including, without
limitation, the Fair Labor Standards Act of 1938, as amended.

 

I.                                         The representations and obligations set forth
herein shall be continuing and shall be binding upon the Seller and his or its
heirs, executors, administrators, successors and/or assigns, whichever the case
may be, and shall inure to the benefit of Fisher Scientific Company
L.L.C., a Delaware limited liability company, its successors and assigns and to
the benefit of its officers, directors, agents and employees and their heirs,
executors, administrators, and assigns.

 

J.                                        The agreements and obligations of Seller set
forth in this Guaranty are in consideration of purchases made by Fisher from
Seller and said obligations are in addition to (and supersede to the extent of
any conflict) any obligations of Seller to Fisher or Fisher to Seller. This
Guaranty shall be effective upon the first sale to Fisher of any Product by Seller,
and the obligations of Seller under this

 

Guaranty shall survive and be enforceable in
accordance with its terms.

 

 

	
  SELLER

  
	
   

  
	
  BIOSITE INCORPORATED

  	
   

  
	
  Name Under Which Seller’s Business is Conducted

  
	
   

  
	
  /s/  Tom
  Watlington

  	
   

  
	
  Signature of Authorized Representative

  
	
   

  
	
  Executive Vice President
  and COO

  	
   

  
	
  Title

  
	
   

  
	
  October 19, 2005

  	
   

  
	
  Date

  
	
   

  
	
  FISHER SCIENTIFIC COMPANY L.L.C., a 

  Delaware limited liability company

  
	
   

  
	
  /s/ Kirk Kimler

  	
   

  
	
  Signature of Authorized Representative

  
	
   

  
	
  President and GM

  	
   

  
	
  Title

  
	
   

  
	
  October 19, 2005

  	
   

  
	
  Date

  

 

39

 

SCHEDULE B

 

[***]

 

	
  Catalog

  Number

  	
   

  	
  Product

  	
   

  	
  Size

  	
   

  	
  List Price

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  300 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  300 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  300 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 test

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  6x5 mL vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  6x5 mL vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  6x5 mL vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  2x2 vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 each

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25/pkg

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25/pkg

  	
   

  	
  [***]

  

 

***Confidential Treatment Requested

 

40

 

SCHEDULE C

 

[***]

 

	
  Catalog

  Number

  	
   

  	
  Product

  	
   

  	
  Size

  	
   

  	
  List Price

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  20 tests

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  20 tests

  	
   

  	
  [***]

  

 

***Confidential Treatment Requested

 

41

 

SCHEDULE D

 

[***]

 

	
  Catalog

  Number

  	
   

  	
  Product

  	
   

  	
  Size

  	
   

  	
  List Price

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 test

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  2 x 2 vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  3 vials

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  2 x 2 vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  3 vials

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 Test

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  1 unit

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  1 unit

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 kits

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  

 

***Confidential Treatment Requested

 

42

 

SCHEDULE E-1

 

[***]

 

	
  Catalog

  Number

  	
   

  	
  

  Product

  	
   

  	
  

  Size

  	
   

  	
  

  List Price

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  
									

 

***Confidential Treatment Requested

 

43

 

SCHEDULE E-2

 

[***]

 

	
  Catalog

  Number

  	
   

  	
  

  Product

  	
   

  	
  

  Size

  	
   

  	
  

  List Price

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  2x2 vials

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  100 test

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [***]

  

 

***Confidential Treatment Requested

 

44

 

SCHEDULE F

 

[***]
PRICES

 

	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

45

 

	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Year

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

46

 

SCHEDULE G

 

FHC
SUBDISTRIBUTORS

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

47

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

48

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

49

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

50

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

51

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

52

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

53

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

54

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

55

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

56

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

57

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

58

 

SCHEDULE H

 

[***]

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  Cardiac

  	
   

  	
  Micro

  	
   

  	
  DOA

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  

 

[***]

 

[***]

 

***Confidential Treatment Requested

 

59

 

SCHEDULE I

 

PRODUCT WARRANTY

 

Biosite’s express and implied warranties (including implied warranties
of merchantability and fitness) are conditioned upon observance of Biosite’s
published directions with respect to the use of Biosite’s diagnostic products.
Remedies against Biosite for breach of warranty or other duty are limited
solely to replacement or return of the purchase price of the affected products.
Any such claim against Biosite must be made in writing and promptly pursued
within one year from the date of delivery of goods. UNDER NO CIRCUMSTANCES
WHATSOEVER SHALL BIOSITE BE LIABLE FOR ANY INDIRECT OR CONSEQUENTIAL DAMAGES.

 

60

 

SCHEDULE J

 

CONTRACT CUSTOMER INSERT

 

A.                                   “The terms and conditions
contained in any invoice, sales acknowledgment, bill of lading, or other
document supplied by Distributor to Customer shall (a) govern the
relationship between Distributor and the Customer and (b) supersede any
inconsistent terms and conditions of this Agreement and any exhibits attached
hereto with respect to the terms of shipment and payment terms for Products
delivered to Customer by the Distributor (which terms include, without
limitation, acceptance, damage or loss in transit, credit terms, payment terms,
and shipping terms, but exclude any warranty terms (which warranty terms shall
be solely as expressly set forth in this Agreement)).”

 

B.                                     “Notwithstanding anything to
the contrary contained in this Agreement, Customer acknowledges and agrees that
it shall look only to Biosite (in accordance with the terms of this Agreement)
and not to Distributor with respect to (i) warranty issues associated with
the Products, (ii) product liability issues associated with the Products (unless
to the extent caused by Distributor’s negligence or willful misconduct), (iii) third
party intellectual property claims related to the Products, and (iv) indemnity
obligations of Biosite set forth in this Agreement.”

 

Biosite and FHC agree that clause (iv) set forth in paragraph (B) above
shall only be included in Contract Customer contracts in the event that Biosite
has agreed to provide indemnity to the applicable Contract Customer.

 

61

 

SCHEDULE K

 

TRANSFER PRICES

 

	
  Biosite

  	
   

  	
  Fisher

  	
   

  	
  Product Description

  	
   

  	
  Transfer

  	
   

  
	
  Part#

  	
   

  	
  Catalog#

  	
   

  	
  Description

  	
   

  	
  Price

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  [***]

  	
   

  	
  $

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

62

 

SCHEDULE L

 

[***]

 

	
  Catalog 

  Number

  	
   

  	
  Product

  	
   

  	
  Size

  	
   

  	
  Price

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  2 x 2 vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  5 x 1 vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 x 5 vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  2 packs, 50 tests/pack

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 Unit

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 Unit

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 Unit

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 CD

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 set

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 Unit

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  2 x 2 vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  1 x 5 vials

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  2 x 2 vials

  	
   

  	
  [***]

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

63

 

	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  6 x 5
  vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  6 x 5
  vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  6 x 5
  vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  20 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  20 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  10 test
  kit size

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  3 vials

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

64

 

SCHEDULE M

 

OBLIGATIONS FOR [***]

 

With respect to [***],
Biosite shall perform the obligations set forth below for the remainder of
the Term.

 

[***]

 

With respect to [***], FHC
shall perform the obligations set forth below for the remainder of the
Term.

 

[***]

 

[***]

 

***Confidential Treatment Requested

 

65

 

SCHEDULE N

 

[***]

 

 

	
  Catalog 

  Number

  	
   

  	
  Product

  	
   

  	
  Size

  	
   

  	
  List Price

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  25 tests

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  5x.25 ml

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  5x.25 ml

  	
   

  	
  [***]

  	
   

  
	
  [***]

  	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  10x.25ml

  	
   

  	
  [***]

  	
   

  

 

***Confidential Treatment Requested

 

66

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]